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Summary
While a large body of work has focused on the transcriptional regulation
of cellular identity, the role of the mechanical properties of cells and the
importance of their physical interactions with the local environment remains
less well understood.
In this project, we explored the impact of cytoskeleton-generated forces
exerted on the nucleus in the context of early embryonic stem (ES) cell fate
decisions. We chose to perturb force generating components in the cytoskele-
ton notably the molecular motor non-muscle myosin II - and key structural
and chromatin binding proteins in the nuclear envelope, notably, the lamins
(LMNA), Lamin B receptor (LBR) and components of the LINC complex
(nesprins/KASH). The structural proteins in the nuclear envelope regulate
both the mechanical response of the nucleus to force and the stabilization
of peripheral heterochromatin (repressed genes). Our hypothesis is that re-
ducing forces transmitted directly to chromatin or increasing tethering of
peripheral heterochromatin to the nuclear envelope would restrict access to
lineage specific genes sequestered at the nuclear lamina and thereby either
impair, or delay, diﬀerentiation.
We found phenotypes in the capacity of mouse ES cells to specify to the
neural lineage following our perturbations: overexpression of LMNA, LBR
and KASH proteins resulted in a significant fraction of cells that did not
express the neuroectoderm marker Sox1 after four days of diﬀerentiation,
while inhibiting non-muscle myosin II delayed Sox1 expression in the entire
population. Overexpression of LMNA and LBR did not aﬀect the ability of
the cells to exit the naive pluripotent state, which raises the possibility that
the perturbations are halting the cells in a formative phase prior to lineage
specification. Future work will focus on looking at genome-wide transcrip-
tional changes accompanying diﬀerentiation combined with an analysis of
spatial information of diﬀerentially regulated genes.
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Outline
Chapter One introduces, motivates and presents the background knowl-
edge pertinent to the this project. I will give an overview of the components,
structure and organisation of the nucleus, focusing on the higher-level reg-
ulation of transcription at the nuclear envelope in the context of embryonic
stem cell di↵erentiation. Secondly I will describe mechanotransduction and
how forces might directly influence nuclear dynamics and facilitate transcrip-
tional changes.
Chapter Two will present data from the start of the project exploring
chromatin mobility. The hypothesis and goals of the project will also be
introduced and discussed.
Chapter Three presents the materials and general methods used through-
out the project. Methods that are specific to individual Chapters are dis-
cussed within the Chapters themselves.
Chapter Four examines nuclear shape changes and outlines our meth-
ods for their characterisation. We explore which elements in the actomyosin
cytoskeleton are responsible for driving nuclear shape changes and deter-
mine whether there is a relationship between local distributions of actin and
fluctuations in the nuclear envelope.
Chapter Five introduces the perturbations of the nuclear envelope. I
will explore how the perturbations a↵ect nuclear shape, dynamics and look
at whether they can modulate the distributions of epigenetic histone modifi-
cations, primarily focusing on repressive histone modifications at the nuclear
periphery.
Chapter Six presents data that explores how our perturbations of the
nuclear envelope and nuclear shape changes influences the capacity of em-
bryonic stem cells to specify to the neural lineage. I also explore whether
the perturbations a↵ect the ability to exit the naive pluripotent state.
Chapter Seven presents data from current work followed by an overall
discussion of what was achieved in the project and to what extend the goals
have been met. I tie together and provide a summary of each Chapter and
discuss the future directions in which the work can be developed.
xii
Chapter 1
Introduction and background
Embryonic stem (ES) cells possess the capacity to self-renew and to become
any cell type in the body. The potential to exploit these properties makes
them a powerful tool. Firstly, embryonic stem cells can be used to model
disease; they can be genetically modified in-vitro and re-introduced into the
developing embryo to create model organisms. The genetic modifications
create the diseased state in the organism (e.g. mouse), mimicking that of
humans. Such model organisms provide a powerful platform with which to
study disease and devise treatments. Secondly, embryonic stem cells can
be used to study embryogenesis, knowledge of which is invaluable for both
understanding abnormal developmental processes and manipulating cell fate
for therapeutic purposes. To this end, embryonic stem cells have enormous
potential to enhance the field of regenerative medicine. Lastly, embryonic
stem cells can provide an unlimited source of specialised adult cells with
which to discover and test new drugs.
A thorough understanding of how embryonic stem cells regulate them-
selves and determine their fate is a key research goal. One approach has
been to dissect the genetic regulatory networks that define embryonic stem
cell identity and underpin fate transitions. A decade ago, this led to the
discovery of four key transcription factors which, when expressed in somatic
cells, reprogram them back into an embryonic stem cell like state (Takahashi
& Yamanaka, 2006). With the development of next generation sequencing
technologies, coupled with advances in bioinformatics, attention has turned
to acquiring data of global transcriptional changes during development at the
resolution of individual cells (Wen & Tang, 2016). These studies promise to
provide deep insights into the temporal dynamics of embryonic stem cell
di↵erentiation (Semrau et al. , 2016) (Guo et al. , 2017).
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A second approach is to explore how embryonic stem cells interact with
their surroundings. An embryonic stem cell is not an isolated unit; it must
be able to receive biochemical and biophysical cues from the local environ-
ment and respond at both the protein and transcriptional levels. While
biochemical signalling pathways have been extensively studied, the mecha-
nisms by which the cell transduces and responds to forces, generated and
applied both internally and externally, are not as well understood. Mes-
enchymal stem cells have been shown to sense the physical properties of the
local micro-environment - such as sti↵ness and geometry - by actively ex-
erting forces on the surrounding matrix which, in turn, can direct their fate
(McBeath et al. , 2004) (Engler et al. , 2006). The mechanisms through
which forces manipulate cell fate, however, have remained largely elusive.
Recent work has highlighted the importance of forces acting on the nucleus:
it has been shown that applying mechanical strain to human epidermal multi-
potent stem/progenitor cells can block the expression of lineage commitment
genes by directly reorganising chromatin. This reorganisation is mediated
by mechanically sensitive components of the nuclear envelope (Le et al. ,
2016).
The organisation of chromatin and the structure of the nuclear envelope
in embryonic stem cells, however, di↵ers from that of more specialised stem
cells and somatic cells. Embryonic stem cells possess a more open and dy-
namic chromatin structure (Meshorer et al. , 2006) (Gaspar-Maia et al. ,
2011). Major structural proteins, e.g. Lamin A and C, which are implicated
in mechanical sensing (Swift et al. , 2013) (Buxboim et al. , 2014), are also
expressed at low levels and largely absent from the nuclear envelope (Con-
stantinescu et al. , 2006) (Eckersley-Maslin et al. , 2013). It is unknown
whether embryonic stem cells possess similar mechanical sensing pathways
and, given the di↵erences in nuclear organisation, what e↵ect they might
have on the function of the cells if they are present. The goal of this project
is, therefore, to explore the role of forces acting on the nuclei of embryonic
stem cells in the context of embryonic stem cell fate decisions.
1.1 Embryonic stem cells
Mouse embryonic stem cells are isolated from the inner cell mass of the
pre-implantation blastocyst at embryonic day 3.5 (E3.5) and can be main-
tained in in vitro culture (Evans & Kaufman, 1981) (Martin, 1981). ES cells
are characterised by their capacity to indefinitely self-renew and to form
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chimeras, contributing to all somatic cell lineages and the germ line, a prop-
erty known as pluripotency (Nichols & Smith, 2012). In vitro culture of
embryonic stem cells provides several advantages over in vivo studies, an
important proponent of which is the ability to fine-tune the local microen-
vironments in which the cells reside. This has allowed the processes that
govern the establishment, regulation and subsequent exit from the pluripo-
tent state to be more readily explored. Advances in mouse ES cell culture
have led to the development of the medium known as 2i (Ying et al. , 2008):
by combining chemically-defined base medium (N2B27) with inhibitors of
mitogen-activated protein kinase (MAPK) and glycogen synthetase kinase-3
(GSK3) signalling pathways, mouse embryonic stem cells are restricted to a
transcriptionally homogeneous naive pluripotent state. Additionally, activa-
tion of the transcription factor STAT3 by adding leukaemia inhibitory factor
(LIF) enhances mouse ES cell proliferation and inhibits di↵erentiation (Ying
et al. , 2003).
Di↵erentiation is a tightly regulated process that relies on external chem-
ical and physical cues from neighbouring cells and the extracellular matrix.
In vitro, mouse ES cell di↵erentiation is coupled to changes in cell morphol-
ogy that accompany global transcriptional changes. Figure 1.1 outlines the
model of the initial phases of mouse ES cell di↵erentiation, prior to lineage
specification:
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2i/LIF
Naive Transition Formative
2i/LIF 24hr N2B27 48hr N2B27
Figure 1.1: Mouse ES cell di↵erentiation and morphology. ES cells
are restricted to the naive pluripotent state by culturing in 2i/LIF where
colonies are round and tight. During di↵erentiation, the colonies break apart
and flatten; after 24hrs in N2B27 the cells are transiting between the naive
phase and the formative phase which represents the final timepoint that
naive pluripotency can be recovered by adding 2i/LIF. After 48hrs in N2B27
the cells are in the formative phase prior to lineage specification.
Upon removal of the 2i inhibitors and LIF, mouse ES cells start to disas-
semble their naive pluripotency network, shutting down naive pluripotency
factors such as Nanog and Klf4. This process is largely complete after 24
hours and the cells are in a transition phase after which the naive state can
no longer be recovered by re-introducing the 2i inhibitors. The cells then
enter a formative phase, transiently expressing factors such as Pou3f1 and
Otx2, where they gain the capacity to rapidly respond to di↵erentiation sig-
nals. The end of the formative phase is marked by linage commitment and
a functional loss of germ-line capacity, which occurs roughly 72 hours after
2i/LIF withdrawal. Neural lineage commitment is marked by expression of
the transcription factor Sox1. This is the default lineage that ES cells will
commit to when cultured in N2B27 in vitro. It is worth mentioning that the
cells may be restricted to the pluripotent state by culturing in 2i without
LIF and that this speeds up exit from naive pluripotency by 12 hours.
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1.2 The organisation of the nucleus
The nucleus is a complex and highly organised organelle. At a fundamental
level the bulk of the nucleus is made up of negatively charged DNA wrapped
around positively charged proteins called histones. The DNA and associated
proteins, collectively known as chromatin, can compact by coiling around it-
self at multiple length scales (heterochromatin), or unwind where it can
be easily accessed by the transcriptional machinery of the nucleus (euchro-
matin). Chromosome conformation capture technology has revealed that
chromosomes exhibit the properties of a fractal globule, possessing conserved
internal structure with DNA organised into domains on the megabase scale
(Lieberman-Aiden et al. , 2009). Increasing the resolution to look at individ-
ual cells (single cell Hi-C) has found that, while intra-chromosomal domain
structure is well conserved, there is significant variability in the organisation
of chromosome territories between cells (Nagano et al. , 2014). A recent
study has shown that the chromatin in human embryonic stem cells under-
goes significant re-organisation during lineage specification. While chromo-
somal domain boundaries remain intact there is significant re-structuring
both within and between domains (Dixon et al. , 2015).
1.2.1 Histone structure and modifications
Histone proteins are an integral component in the organisation and struc-
ture of DNA and form a template upon which information can be stored and
passed to daughter cells. Information is encoded by modifying the structure
of histone proteins which, in turn, influences whether the gene that they
are bound to is transcribed, or repressed. Histone proteins form nucleo-
somes, which comprise a core histone 3/histone 4 (H3/H4) tetramer flanked
by two histone 2A-histone 2B (H2A-H2B) dimers, around which the DNA is
wrapped - a diagram of which is shown below in Figure 1.2. Every histone
possesses an amino acid tail which protrudes from the nucleosome that can
be enzymatically modified. The most prevalent types of histone modification
are the acetylation and methylation of lysine (K) residues. Histone acetyla-
tion is enriched in open chromatin regions and at active sites of transcription
while histone methylation, dependent on the number of methyl groups and
on which residue, is associated with both transcriptional activation and re-
pression. Histone ubiquitination has been implicated in both the regulation
of transcription and the DNA damage response (Cao & Yan, 2012). The
most highly modified histone is H3 which can drive both gene repression
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and heterochromatin formation through methylation of H3K9 and H3K27
(H3K9me2/3 and H3K27me3) or gene activation by methylation of H3K4
(H3K4me1/3) (Bannister & Kouzarides, 2011).
MethylationAcetylation Ubiquitination
Histone Modifications
H3 H4
H2BH2A
DNA
Histone tail
Figure 1.2: Nucleosome structure and histone modifications.
The information contained within the distribution of histone modifica-
tions is passed on to daughter cells during cell division. In contrast to semi-
conservative replication, the method by which the genetic code is copied with
one DNA strand acting as the template for the new strand, the inheritance
of histone modifications is a complicated a↵air with multiple mechanisms.
When the DNA is copied, parental histones are segregated and deposited
onto both the template DNA and the newly synthesised strand (Annunziato,
2015). Histones are released ahead of the replication fork and deposited be-
hind with the help of a network of histone chaperone proteins. During DNA
replication, histone chaperone proteins ensure the correct interactions be-
tween histones and DNA and guide chromatin assembly (Burgess & Zhang,
2014). One mechanism of epigenetic inheritance of histone modifications
is the dilution model: prior to DNA synthesis, sequences of DNA are en-
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riched in their constituent histone modifications - in particular sequences
containing H3K4me3 and/or H3K27me3 (Lanzuolo et al. , 2012). These
modifications are then diluted out when the histones are segregated at the
replication fork. This ensures that the distribution of histone modifications
is passed on accurately, and that both template and newly synthesised DNA
are not without the requisite modifications for any length of time - which
might otherwise alter their regulation. Another mechanism relies on the
recruitment of histone modifying enzymes to the replication fork, mediated
through interactions with the replication machinery (Moldovan et al. , 2007).
These enzymes then re-establish the histone modifications during DNA syn-
thesis (Peng et al. , 2015) (Lowe et al. , 2016). Finally, propagation of DNA
methylation during replication, through DNA methylases recruited to the
replication fork, act as a template on which histone modifying enzymes are
recruited and subsequently act to re-establish the post-translational histone
modifications (Zhang et al. , 1999) (Liao et al. , 2015).
1.2.2 The nuclear lamina
In the vast majority of cell types the heterochromatin resides at the nuclear
periphery where it interacts with the nuclear lamina. The nuclear lamina is
formed from a network of intermediate filament proteins that forms sca↵old
beneath the nuclear envelope. The primary constituents of the nuclear lam-
ina are A-type (LMNA) and B-type (LMNB1 and LMNB2) lamins. Lamins
A and C are created by alternate splicing of the Lmna gene and are devel-
opmentally regulated whereas the B-type lamins are ubiquitously expressed
in all cell types. It has been shown that the A-type lamins regulate nuclear
mechanics and contribute to nuclear sti↵ness, whereas the B-type lamins
contribute to nuclear integrity, but not to sti↵ness (Lammerding et al. ,
2006). In a later study it was found that the levels of LMNA scale with
tissue elasticity: cells that undergo high strain rates, e.g. muscle and con-
nective tissue, express LMNA at high levels. It is thought that, because
LMNA sti↵ens the nucleus, high levels of LMNA protect the nucleus from
rapid deformation and subsequent DNA damage (Swift et al. , 2013). It was
originally thought that ES cells do not express LMNA (Constantinescu et al.
, 2006); however, it has been shown by the authors in Eckersley-Maslin et al.
(2013) that LMNA is present, but expressed at low levels. Nevertheless, in
ES cells, the B-type lamins are the dominant lamins and their nuclei are
correspondingly soft.
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The lamins play an integral role in orchestrating higher-order chromatin
organisation, regulating transcription and DNA replication (Prokocimer et al.
, 2009). In particular, the lamins are implicated in binding peripheral het-
erochromatin, anchoring it to the nuclear envelope where transcriptional
repression is stabilised (Peric-Hupkes & van Steensel, 2010). Studies have
shown that proximity to the nuclear envelope plays an active role in re-
pressing genes; movement of regions of chromatin to and from the nuclear
envelope allows genes to be reversibly silenced (Finlan et al. , 2008) (Reddy
et al. , 2008) (Zullo et al. , 2012). Figure 1.3 depicts two mechanisms pro-
posed by Solovei et al. (2013) for tethering peripheral heterochromatin; a
lamin b receptor tether (LBR) that interacts with B-type lamins and an
A-type lamin tether. As ES cells are largely deficient in LMNA, the LBR
tether might act as the primary mechanism.
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Figure 1.3: Mechanisms of heterochromatin tethering to the nu-
clear envelope. The nuclear lamins are thought to be responsible for an-
choring heterochromatin to the nuclear envelope through independent A-
type and B-type lamin mechanisms. ES cells do not express A-type lamins
which would make the proposed LBR tether the dominant mechanism. Solid
circles represent binding interactions. The dotted circles indicate that di-
rect chromatin binding of B-type and A-type lamins is not su cient for,
but might synergistically enhance, heterochromatin tethering. Figure taken
from Solovei et al. (2013).
1.2.3 Lamin associated domains and di↵erentation
Chromatin interacts with the nuclear lamina in regions termed lamin as-
sociated domains (LADs). LADs are enriched with the repressive histone
modifications H3K27me3, H3K9me2 and H3K9me3, which are necessary for
the binding of chromatin to the nuclear lamina, facilitated by the recruit-
ment of lamin/chromatin binding proteins (Guelen et al. , 2008)(Kind et al.
, 2013)(Harr et al. , 2015).
The technique known as Dam-ID has allowed the interactions between
the nuclear lamina and the LADs to be mapped dynamically. Dam-ID relies
on the fusion of DNA adenine methyltransferase (Dam), absent in eukary-
otes, to a protein of interest (Vogel et al. , 2007). Whenever the fusion
9
protein is in close proximity to DNA, the palindromic sequence GATC is
methylated. The genome is then sequenced and regions that are enriched
in DNA methylation are known to have been in close proximity/interacted
with the fusion protein. A challenge to this technique is that any freely
di↵using Dam (there will always be some) will methylate everywhere in the
genome. This can be controlled for by expressing freely di↵using Dam in
a control population and using the results to normalise the data. The au-
thors in Peric-Hupkes et al. (2010), fusing Dam with lamin B1, explore how
the LADs change dynamically during ES cell neural di↵erentiation - Figure
1.4. In the naive pluripotent state they show that the nuclear lamina is
enriched in repressed neural lineage genes while the pluripotency genes are
internalised in the nucleus. During di↵erentiation this organisation reverses:
the pluripotency genes become enriched at the nuclear envelope and are con-
comitantly silenced, while the lineage genes are unlocked and move inwards.
The authors also find that not every gene is expressed when unlocked from
the nuclear lamina, but can be poised for transcription at a later stage in
the di↵erentiation process.
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Figure 1.4: Lineage and pluripotency gene positioning at the nu-
clear envelope during neural di↵erentiation. Neural lineage genes are
locked at the nuclear periphery in the pluripotent state. During di↵erentia-
tion into neural precursor cells (NPCs) the stem cell genes are silenced and
are sequestered to the nuclear lamina while the neural genes are unlocked
and move inwards, where they are transcribed or poised for activation at a
later stage of di↵erentiation. Figure taken from Peric-Hupkes et al. (2010).
1.3 The cytoskeleton
The ability of a cell to generate and respond to forces necessary for interact-
ing with the physical properties of the local micro-environment is governed,
in part, by the complex and dynamic interactions of a set of regulatory pro-
teins and filamentous polymers in the cytoplasm, known collectively as the
cytoskeleton. The cytoskeleton is not a rigid structure: it is highly adaptable
and is continuously being re-organised in order to meet the needs of the cell,
both external - responding to cues in the environment (e.g. the need for
movement/migration) - and internal - providing structure and maintaining
cellular compartments/organisation (Fletcher & Mullins, 2010).
The filamentous polymers that make up the cytoskeleton fall into one of
three categories - microtubules, actin filaments and intermediate filaments,
with each possessing distinct physical properties. The most rigid of the
polymers are the microtubules, which have a persistence length in the region
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of 4-8 mm (Gittes et al. , 1993) (Janson & Dogterom, 2004) and are capable
of bearing compressive loads (Brangwynne et al. , 2006). Persistence length
is a mechanical property which provides a measure of polymer sti↵ness - it is
defined as the length at which correlations in the direction of the tangent to
the polymer are lost. During mitosis and meiosis, microtubules form a crucial
component in the cellular replication machinery where they are involved in
the alignment and separation of chromosomes (Inoue´ & Salmon, 1995) while,
during interphase, they provide the backbone for inter-cellular tra cking.
Microtubules possess complex growth dynamics: they switch from slowly
assembling to rapidly disassembling during an event known as a ’catastrophe’
(Mitchison & Kirschner, 1984). By altering the kinetics of polymerisation,
depolymerisation and the rate of catastrophe, the cell controls the structure
and organisation of the microtubule network.
The second type of cytoskeletal polymer are the actin filaments which,
possessing a persistence length of approximately 20 µm, are much less rigid
than microtubules. Actin filaments are capable of forming cross-linked net-
works which are more rigid and able to exert and propagate stresses when
compared with individual filaments. The organisation of the actin network
is controlled by the regulation of polymerisation and cross-linking: actin can
assemble in tightly polarised bundles which can support filopodia and form
contractile stress fibres (Mattila & Lappalainen, 2008)(Pellegrin & Mellor,
2007), or be assembled into a branched network that is required for cell
migration (e.g. lamellopodia) or phagocytosis (May & Machesky, 2001).
The final type of polymers are the intermediate filaments which are less
rigid than actin and can be cross-linked together and interact with the actin
and microtubule networks through plectins (Wiche, 1998). An example of
an intermediate filament network has already been introduced in the form
of the lamins that underlie the nuclear envelope.
The actin and microtubule networks are capable of bearing and propa-
gating forces generated through the action of molecular motors, the direction
of movement of which is established by the polarity of the microtubule and
actin filaments. Motors specific to microtubules - from the dynein and ki-
nesin family of proteins - are used to carry cargo around the cell as well as
play an integral role in assembling the microtubule network. Motors specific
to actin - from the myosin family of proteins - also play a critical role in
the assembly of the actin cytoskeleton and, by acting on neighbouring actin
filaments, create contractility in the cell. Myosin-generated tension exerts
forces both on the extracellular environment and on intracellular structures,
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for instance, to stabilise both cell-cell junctions and create mature focal ad-
hesions (Cavey & Lecuit, 2009)(Oakes et al. , 2012).
1.4 Mechanotransduction
Mechanotransduction is the process of converting mechanical stimuli into
signals that elicit a cellular response. In a majority of cases, forces are con-
verted into biochemical signals, mediated by proteins that undergo structural
rearrangement and a concomitant shift in function. To name just a few ex-
amples: pressure waves in the cochlea are transduced into electrical nerve
impulses (Hudspeth, 2014); ion channels on the surface of the cell open in
response to membrane tension (Martinac, 2004); and shear stress exerted
by the blood on epithelial cells regulate arterial structure and atherogenesis
(Hahn & Schwartz, 2009). While conversion of forces into biochemical signals
is the most extensively studied mechanism of mechanotransduction, it has
been postulated that forces may be propagated through the cytoskeleton to
the nucleus where they would influence chromatin structure and transcrip-
tion directly (Wang et al. , 2009). Figure 1.5 outlines the cellular components
involved in this process:
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Figure 1.5: Propagation of forces to the nucleus. There is a direct
physical link between the surface of the cell and the chromatin in the nucleus.
Forces can be propagated through the cytoskeleton, when under tension, to
the nucleus directly impacting the structure of chromatin. Figure taken from
Wang et al. (2009).
There is a direct physical link from adherens junctions and focal adhe-
sions on the surface of the cell to the chromatin in the nucleus: adherens
junctions and focal adhesions that are attached, respectively, to neighbour-
ing cells or the extracellular matrix are bound by their cytoplasmic domain
to actin filaments which, in turn, bind a family of proteins called the ne-
sprins. The nesprins localise to the outer nuclear membrane (ONM) where
their KASH domain at the C-terminal end binds the luminal SUN domain of
the inner nuclear membrane (INM) proteins SUN1 and SUN2, forming the
LInker of Nucleoskeleton and Cytoskeleton (LINC) complex, that interacts
with the nuclear lamina and chromatin. The nesprins are also capable of
binding other components of the cytoskeleton, with four separate nesprin
genes currently identified: the N-terminal domains of nesprins 1 and 2 bind
actin; nesprin 3 binds plectin and by extension the intermediate filaments;
and nesprin 4 binds to a subunit of the molecular motor kinesin-1 which inter-
acts with the microtubule network (Rajgor & Shanahan, 2013). A physical
connection is, by itself, not su cient to transmit forces: by analogy with two
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people pulling on opposite ends of a rope, if the rope is coiled and pulled by
one party, the other will not experience a force until the rope has uncoiled
and there is tension. Similarly, there must be tension in the cytoskeleton to
transmit forces exerted on the adherens junctions (or generated internally)
to the nucleus. This tension is, to a large extent, generated by the action of
molecular motors, notably non-muscle myosin II, which pull on neighbouring
actin filaments, in addition to the forces created by the polymerisation of
actin.
The nuclear lamina plays an important role in mediating forces transmit-
ted through the LINC complex. In Section 1.2 we discussed the finding that
LMNA scales with tissue elasticity and that, in high strain environments,
high levels of LMNA might protect the nucleus from deformation and DNA
damage. The authors in Swift et al. (2013) show, specifically, that LMNA
is mechanically regulated. The mechanism for this is as follows: when the
nuclear lamina is put under tension from external forces, LMNA in the net-
work changes its structural conformation and is no longer recognised by the
kinase responsible for its phosphorylation, which leads to solubilisation from
the nuclear lamina and degradation. While under tension and unfolded, the
half-life of LMNA increases dramatically and the concentration of LMNA
builds up in the nuclear lamina. When the concentration of LMNA is high
enough, the tension per molecule drops and LMNA adopts its unstressed
conformation where it is then targeted for phosphorylation and degradation.
The concentration of LMNA in the nuclear envelope is tuned and scales with
the magnitude of forces on the nucleus where it bu↵ers the forces transmitted
to the chromatin.
Mechanical stress that acts directly on chromatin has the potential to
alter and facilitate transcriptional changes. Recent work by Le et al. (2016)
has highlighted the importance of mechanical forces acting at the nuclear en-
velope by uncovering a mechanosensitive pathway in mouse epidermal stem
cells that influences lineage commitment and tissue morphogenesis. The au-
thors show that exposing epidermal stem cells to cyclic mechanical strain re-
sults in an accumulation of polymerised actin and non-muscle myosin IIA at
the nuclear envelope and the redistribution of emerin from the inner nuclear
envelope to the outer nuclear envelope. Emerin depletion at the inner nuclear
membrane led to a loss of H3K9me2/3 and a re-arrangement of chromatin
at the nuclear envelope (H3K9me2/3 is required for LAD/nuclear lamina
tethering). The loss of H3K9me2/3 was compensated for by an increase in
H3K27me3, which maintained transcriptional repression of heterochromatin.
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Force driven enrichment of H3K27me3 at lineage specific genes resulted in
a block in lineage specification, which was abrogated by small molecule in-
hibition of non-muscle myosin IIA.
In addition, a recent study by Tajik et al. (2016) has provided further
evidence for the importance of forces acting on chromatin in the regulation
of transcription. The authors used ferromagnetic beads attached to the sur-
face of epithelial (CHO) cells via focal adhesion complexes to apply cyclic
stresses to the cells. Chromatin was visualised with enhanced green fluores-
cent proteins (EGFP) targeted to evenly spaced sites within BAC constructs
stably integrated into the CHO cell genome, the relative movement of which
provided a read-out of chromatin deformation. The authors found that the
distance between neighbouring EGFP spots was found to be a function of
the cyclic stress and that, when a stress of constant amplitude was applied,
all EGFP spots moved in the same direction synchronously but with a phase
lag. Gene expression of the transgene inserted in the BAC constructs (dihy-
drofolate reductase - DHFR) was found to increase when cyclic strain was
applied to the cells (by RNA fluorescence in-situ hybridisation). Addition-
ally, quantification of RNA Polymerase II binding near GFP spots showed
an increase five seconds after the application of stress. This provides strong
evidence to suggest that the transcriptional machinery is poised to assemble
and initiate transcription as the chromatin is unfolded and made accessible
by forces acting directly on it. Finally, the authors showed that targeting
actomyosin contractility or disrupting actin filaments with small molecule
inhibitors led to a downregulation in DHFR expression, while increasing
contractility led to an upregulation.
Taken together these studies highlight the importance of forces, propa-
gated through the cytoskeleton when under tension, acting directly on chro-
matin in the mechanical regulation of transcription and cell fate decisions.
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Chapter 2
Materials and methods
A list of kits and reagents used can be found in Appendix A.6. All other
chemicals were obtained from Sigma-Aldrich or Thermo Fisher Scientific.
2.1 Cloning
Plasmids were constructed using either the Invitrogen™ Gateway™ cloning
system or by In-Fusionr (Clontechr). Inserts were created by PCR amplifi-
cation with Q5 Hot Start High-Fidelity DNA Polymerase using either mouse
embryonic fibroblast (MEF) cDNA or the relevant plasmid as a template.
The inserts were run on a 1% agarose gel and purified using a QIAquick
Gel Extraction Kit (Qiagen). Plasmids were transformed into E. cloni 10G
Chemically Competent DUOs, extracted using either a Plasmid Mini or Maxi
Kit (Qaigen) and submitted for verification by Sanger sequencing.
A list of the oligonucleotides and plasmids can be found in Appendix
A.1. Plasmids listed as Gateway cloned were created by cloning the desired
insert into pDONR221 and sequencing, followed by moving into pPB-TAP
IRI.
2.2 Routine cell culture
ES cells were restricted to the naive pluripotent state by culturing in N2B27
medium supplemented with inhibitors of mitogen-activated protein kinase
signalling (PD03) and glycogen synthase kinase-3 (Chiron), in addition to
the self-renewal cytokine leukaemia inhibitory factor (LIF), referred to as
2i/LIF. The recipe is detailed in Appendix A.2. Media was kept for up to
one week in the fridge and warmed to room temperature before use.
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Cells were passaged every three days and the media replaced after two
days. Accutase was used to dislodge and separate the cells and removed by
dilution with DMEM and centrifugation at 300 g for 3 minutes. For routine
culture the cells were split using a dilution between 1/10 and 1/20 (judged
by eye) dependent on the density. When accuracy was required, cells were
counted using a Vi-CELL Cell Viability Analyser (Beckman Coulter).
2.3 Cell lines
The E14 Tg2a mouse ES cell line was used to generate the following stable
lines:
• LMNA inducible overexpression (Tet-On)
• LBR inducible overexpression (Tet-On)
• mRFP-KASH inducible overexpression (Tet-On)
• mRFP-KASH L inducible overexpression (Tet-On)
• mRFP-SR-KASH (Tet-On)
• tagRFP-LMNB1
• tagRFP-LMNB1 LifeAct-GFP
The H2B-tomato ES cell line, a kind gift from J.Nichols (Morgani et al. ,
2013), was used to generate the H2B-tomato LifeAct-GFP cell line. Plasmids
were transfected using Lipofectamine 2000 Transfection Reagent and selected
for using the appropriate antibiotic(s) with final concentrations of:
• Zeocin 100 µg/ml
• Hygromycin B 150 µg/ml
• Puromycin 1 µg/ml
• Geneticin (G418) 200 µg/ml
The LMNA and LBR lines were subcloned by passaging 1000 cells from
the polyclonal line into a 10 cm dish. The cells were allowed to grow for
a week and then picked in a laminar flow hood into a 96-well plate and
expanded. Early expansions from a 96-well plate up until a 24-well plate were
done using accutase without centrifugation in order to minimise cell loss; the
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accutase was added to the cells and then diluted directly with culture media
and transferred to a new well. Clonal lines were analysed by qPCR for the
levels of overexpression and several pluripotency factors (Nanog/Klf4) in
2i/LIF and selected based on a comparison with the parental E14 tg2a cell
line.
2.3.1 Proliferation rates
To measure proliferation rates, 4 ⇥ 104 cells were plated into (each of) 6
wells of a 12 well plate in 2i/LIF, per condition. The cells were harvested
at 20 hours intervals and counted while suspended in 1ml accutase in order
to avoid any loses in centrifuging and resuspension - this was not found to
a↵ect cell viability in the short term. All cell counts were obtained by using
a Vi-CELL Cell Viability Analyser (Beckman Coulter). Cell counts were
then plotted on a log scale against time and the doubling time extracted
from the gradient.
2.4 Immunofluorescence
Immunofluorescence (IF) was performed using the following modified proto-
col from Cell Signalling Technologies1:
Blocking Bu↵er: 1X PBS, 0.3% Triton X-100, 5% normal serum.
Antibody Dilution Bu↵er: 1X PBS, 0.1% Triton X-100, 1% BSA.
1. Fix cells in 4% Paraformaldehyde for 10 min. Wash x3 with PBS.
2. Block for 1 hr at room temperature.
3. Remove blocking bu↵er and incubate with primary antibody overnight
at 4°C or for 2 hr at room temperature. Wash 3x with PBS.
4. Incubate with secondary antibody for 1 hr at room temperature. Wash
2x with PBS.
5. Wash for 10 min with Hoechst staining solution (1 µg/ml) twice. Wash
2x with PBS.
Samples were imaged in PBS. Antibodies and their working dilutions are
listed in Appendix A.3.
1“https://www.cellsignal.com/contents/resources-protocols/immunofluorescence-
general-protocol/if” accessed Sept.2016
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2.5 Fluorescence recovery after photobleaching
H2B-eGFP ES cells were passaged onto ibidi dishes at a density of 1 ⇥
104 cells/cm2 in 2i/LIF, or directly into N2B27 when required. FRAP was
performed using an Andor Revolution XD spinning disk confocal with a
Yokogawa CSU-X1 head using a 63x NA 1.4 OIL immersion objective. An
environmental chamber was used to keep the cells at 37°C and supplied with
7% CO2. A region of interest (ROI) was selected within the nucleus and two
images taken before bleaching the ROI with 100% laser power. Post-bleach
images were taken every second for the first 60 seconds and then at 20 second
intervals for the next 180 seconds.
Image analysis was performed using ImageJ and MATLAB. FRAP series
were imported into ImageJ and the bleaching frames discarded. The Stack-
Reg plugin was run to correct for cell rotation or translation. The FRAP
Norm plugin was used to calculate the FRAP intensity using a double nor-
malisation procedure outlined by Phair et al. (2004). This required manu-
ally selecting the following regions: ‘FRAP Region’ (Intensity It) - bleached
region of the nucleus, ‘Background’ (Intensity Bt) - an area outside the cell
and ‘Whole cell’ (Intensity Nt) - region encompassing the nucleus. These
regions were selected from the first post-bleach image and the image series
checked to ensure that they remained correct for the rest. The normalization
procedure was as follows: for every post-bleach image the average whole cell
intensity was divided by its pre-bleach value (Nt/N0). This corrected for
acquisition bleaching. This factor was then multiplied by intensity of the
bleached region of the cell, normalised to its pre-bleach value (It/I0). Before
both of these operations, the relevant reference intensities were subtracted,
giving the final ‘double normalized’ FRAP intensity as:
It Norm =
N0  B0
Nt  Bt ⇥
It  B0
I0  B0 (2.1)
The data sets were then imported into MATLAB.
2.6 Quantitative real-time PCR
RNA was extracted using a RNeasy Mini Kit (Qiagen) with the optional
on-column DNase digestion steps included. cDNA was made using a Super-
Script III First-Strand Synthesis Kit (Invitrogen) in 20 µl reactions with the
amount of template RNA kept constant across the experiment - the lowest
RNA concentration obtained was used to determine the total amount used,
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anywhere between 100 ng and 1 µg. The cDNA was then amplified in 12 µl
reactions (in triplicate) with TaqMan probes using GAPDH as an internal
control. The choice of GAPDH as an internal control was verified through
RNA-Seq data (not shown). A list of TaqMan probes used can be found in
Appendix A.5.
The data was analysed by using the cycle threshold (CT ) values to calcu-
late the fold-di↵erence between the gene of interest and the internal GAPDH
control for each reaction as follows:
Fold of GAPDH = 2 (CT (Target) CT (GAPDH)) (2.2)
The mean and standard deviation of the triplicate reactions was taken
and normalised to the highest expression level of the control samples and
then plotted on a bar graph.
2.7 siRNA knockdown
Knockdown was performed by transfecting E14 Tg2a cells using Lipofec-
tamine RNAiMAX with siRNA at a concentration of 20 µmol. The Lipofec-
tamine/siRNA mix was added to cells after passaging at a density of 3⇥104
cells/cm2. The volumes for a well of a 24-well plate are listed in Appendix
A.4. The ES cells were transfected in the evening and the lipofectamine
was removed early the following morning to limit toxicity. siRNA knock-
down e ciency was analysed using qPCR or by immunofluorescence when
possible.
2.8 Nuclear shape changes
2.8.1 Cell culture and imaging
Nuclear shape experiments were performed on cells either in 2i/LIF or after
48 hrs in N2B27. For experiments in 2i/LIF, ES cells were passaged six
hours before imaging onto laminin-coated ibidi dishes (overnight incubation
at 10 µg/ml at 4°C) at high density (⇠ 3⇥ 104 cells/cm2). For experiments
conducted after culturing in N2B27 for 48hrs, cells were seeded into N2B27
on laminin coated ibidi dishes at a density of 1⇥104 cells/cm2. Live imaging
was performed using either a Leica SP5 confocal microscope or a Zeiss LSM
710 with a 63.0x NA 1.4 oil immersion objective. An environmental chamber
was used to keep the samples at 37°C and supplied with 7% CO2. Cell lines
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that did not possess a fluorescent nuclear marker were incubated with 2
µM SiR-Hoechst for 45 min before washing to label the DNA. Images were
acquired every 10 seconds for either 5 or 10 minutes using as low a laser power
as possible to limit phototoxicity. Samples were imaged for a maximum of
one hour.
2.8.2 Small molecule inhibitors
The H2B-Tomato and E14 Tg2a cell lines were used for the small molecule
inhibitor experiments. Just prior to imaging the media was exchanged with
media contain the inhibitors at the following concentrations: Blebbistatin at
10 µM, Y27632 at 10 µM, Jasplakinolide at 150 ng/ml and Nocodazole at
500 ng/ml.
2.8.3 Analysis - shape change magnitude
The data was analysed using a combination of ImageJ, CellProfiler and
MATLAB. For experiments in 2i/LIF where the cells were all separated,
videos of individual nuclei were extracted manually in ImageJ and the Stack-
Reg plugin was run to correct for any translation or rotation of the nucleus
over the time-course. For experiments in N2B27, where nuclei were more
dense, CellProfiler was first used to identify and track the nuclei using Otsu
thresholding. The images were then exported into ImageJ where individual
nuclei could be extracted and StackReg corrected. The videos were imported
into MATLAB and analysed using the methods introduced and discussed in
Chapter 4.
2.9 Di↵erentiation rescue - kinetics of exit from
naive pluripotency
Embryonic stem cells were passaged into N2B27 from 2i/LIF and plated
onto laminin coated 24-well plates at a density of 1 ⇥ 104 cells/cm2. The
plates were coated with laminin the day before at a concentration of 10
µg/ml and left at 4°C overnight. Before seeding, the plates were warmed
up in the incubator and the laminin replaced with N2B27 and returned to
the incubator to equilibrate. One plate was used for each timepoint at 48
hours and 72 hours, with a control plated into 2i/LIF. At each timepoint,
the cells were unstuck with accutase, re-suspended in 2i/LIF and counted
using the Vi-CELL. The cells were then serial diluted until 400 cells could
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be accurately obtained and then seeded onto laminin coated 24-well plates
(created as above) in 2i/LIF in triplicate. The plates were left for 5-7 days,
until colonies had grown, and then fixed in 4% PFA for 10 minutes. The
plates were then stained with an alkaline phosphatase staining kit, per the
manufacturer’s instructions, and left to air dry. The plates were then scanned
using an Olympus IX51 microscope and the colonies that stained positive
for alkaline phosphatase counted manually in ImageJ.
2.10 Neural lineage specification
Embryonic stem cells were passaged into N2B27 from 2i/LIF and plated
onto laminin coated 24-well plates at a density of 1 ⇥ 104 cells/cm2. The
plates were coated with laminin the day before at a concentration of 10
µg/ml and left at 4°C overnight. Before seeding, the plates were warmed up
in the incubator and the laminin replaced with N2B27 and returned to the
incubator to equilibrate. One plate was made for each timepoint at 24 hours,
48 hours, Day 3 and Day 4 with every perturbation containing a control and
a treated well in duplicate.
Doxycycline was added at a concentration of 1 µg/ml to induce the over-
expressions of LMNA, LBR, mRFP-KASH, mRFP-KASH L and mRFP-
SR-KASH. Blebbistatin was used at a concentration of 2 µg/ml. siRNA
knockdown was performed as detailed in Section 2.7. All perturbations were
introduced when 2i/LIF was withdrawn. The cells at each timepoint were
fixed using 4% PFA for 10 min and stored at 4°C. When all plates were
collected the cells were stained for Sox1 (see Section 2.4).
The cells were imaged using wide-field fluorescence microscopy with ex-
posure, gain and intensity selected to maximise dynamic range using a con-
trol sample at Day 4. The imaging settings were kept constant throughout
the experiment. One set of samples was stained for Sox1 (CST) and the
second set, for LMNA and LBR overexpression, was stained for Sox1 (R&D
Systems) with, respectively, Lamin A (SC-20680) or Anti-Lamin B Receptor
(Abcam).
Images were analysed using CellProfiler: the nuclei were identified and
segmented using global Otsu thresholding and their outlines used to extract
the mean intensities of Sox1 and any other relevant channels. Shape descrip-
tors were extracted from the nuclei. The data was imported into MATLAB
and plotted as a histogram, normalised as a probability distribution.
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2.11 Statistical methods
All statistical analysis was conducted using MATLAB with hypothesis test-
ing done at the 5% level. Data sets were first checked for normality using
the Lilliefors test. Where data was normally distributed, the appropriate
ANOVA was performed. If significant di↵erences were detected, then a post-
hoc multiple comparison test (Tukey’s HSD) was used. Where data was not
normally distributed the non-parametric Kruskal-Wallis test was performed
and, if significant di↵erences were detected, followed by a post-hoc multiple
comparison test (Bonferroni). In figure captions, where appropriate, the fol-
lowing are reported; P values, the number of measurements/samples in each
experiment (n), and the total number of times the experiment was conducted
(N).
24
Chapter 3
Chromatin mobility in
embryonic stem cells
At the beginning of this project, I was interested in exploring chromatin
mobility: a study by Meshorer et al. (2006) had highlighted the highly
dynamic nature of chromatin in pluripotent ES cells when compared with
lineage committed (but undi↵erentiated) cells. The authors’ hypothesis is
that the highly dynamic nature of chromatin in ES cells contributes to their
‘plasticity’ which allows them to enact the global transcriptional and epi-
genetic changes that accompany di↵erentiation. I wished to expand upon
this study and apply it to our cell culture system to ask whether chromatin
dynamics change in the early stages of di↵erentiation - before, and during,
the exit from naive pluripotency.
The cell culture system I am using confers major advantages over the
previous study in which ES cells were cultured in serum/LIF: cells cultured
in 2i/LIF are more transcriptionally homogeneous which means that the
population exits naive pluripotency in a more synchronous fashion when the
inhibitors are removed. In addition, culturing with serum is artificial: serum
presents the cells with a myriad of factors and signals that are uncharac-
terised and not encountered in the embryo. Di↵erentiation from serum/LIF
is asynchronous and proceeds towards both endoderm and mesoderm lin-
eages, in contrast to cells exiting from 2i/LIF which, without additional
factors, commit solely to the neural lineage.
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3.1 Fluorescence recovery after photobleaching
The technique used to look at ES cell chromatin dynamics was fluorescence
recovery after photobleaching (FRAP). The methodology behind FRAP is
to tag a protein of interest with a fluorescent marker and then to destroy
(bleach) all fluorescent molecules in a targeted region with a high intensity
burst from a laser. The cell is then imaged over time and the rate at which
fluorescence intensity recovers in the bleached region provides a quantitative
measure of the kinetics of the tagged protein. An example of the process is
shown below in Figure 3.1, where histone 2B (H2B) has been tagged with
an enhanced green fluorescent protein (eGFP).
Bleached
Region
Post-bleach 600s  Post-bleachPre-bleach
10μm H2B-eGFP
Figure 3.1: Example of FRAP timecourse. Nuclear H2B-eGFP inten-
sity distribution imaged at various stages in a FRAP experiment. Images
taken using an Andor Revolution XD spinning disk confocal. From left to
right: pre-beached cell, cell immediately after bleaching and cell after 600
seconds of recovery.
The H2A/H2B dimers display recovery kinetics on multiple time scales,
shown in Figure 3.2 where the recovery of H2B-eGFP was measured in mES
cells cultured in 2i/LIF and 2 hrs, 24 hrs and 48 hrs post 2i/LIF withdrawal.
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Figure 3.2: Kinetics of H2B-eGFP during ES cell di↵erentiation,
measured by FRAP. Normalised FRAP recovery of H2B-eGFP in mESC
- comparing cells cultured in 2i/LIF with cells allowed to di↵erentiate in
N2B27 at 2, 24 and 48 hour time points. Post-bleach images were taken
every second for the first sixty seconds to capture the recovery dynamics of
the fast di↵using H2B-eGFP fraction. Error bars give the standard error of
the mean. The data was acquired using an Andor Revolution XD spinning
disk confocal microscope. N=2 for 2i/L, 24hr and 48hr timepoints. N=1 for
the 2hr timepoint.
Immediately after bleaching there is a rapid recovery in intensity in the
bleached region, after which recovery slows down. The intensity finally
asymptotes to a value below the (normalised) pre-bleach level (not shown).
The varied recovery kinetics have been attributed by Meshorer et al. (2006)
to di↵erent pools of fluorophores as follows: initial recovery occurs due to
freely di↵using molecules; slow recovery takes place as transiently binding
H2A/H2B, postulated as occurring in euchromatin, moves into the bleached
region; and a final asymptote is reached as there is an immobile pool fluo-
rophores bound in heterochromatin that cannot be replaced. This contrasts
with the recovery kinetics of H3 and H4 which, owing to a higher a nity
for DNA when compared with H2A/H2B, exhibit bimodal kinetics; there
is a freely di↵using pool and an immobile pool, the former of which van-
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ishes upon DNA synthesis as the histones are absorbed into creating new
nucleosomes (Meshorer et al. , 2006).
The data in Figure 3.2 were split into two groups to separate the dynam-
ics; sub 15 seconds was treated as free di↵usion and fit using an exponential
model while post 15 seconds was fit to a linear model. The 15 second cut-o↵
was chosen as it represents time taken for complete recovery of H3/H4-eGFP
due to free di↵usion (Meshorer et al. , 2006). The time constants for the fast
and slow dynamics were extracted from the models and are shown in Figure
3.3.
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Figure 3.3: Di↵usion rates of H2B-eGFP during ES cell di↵er-
entiation. (A) Under 15 second H2B-eGFP recovery dynamics in mouse
embryonic stem cells - dominated by free di↵usion. Values given are the
averages of the time constants for single exponential fits to the data. (B)
Analysis of the slow dynamics (post 15 seconds) - representative of transient
H2B-eGFP nucleosome binding in euchromatin. Values given are the aver-
ages of the gradients from individual FRAP measurements. (A) p = 0.38
(B) p = 0.0087 (Kruskal-Wallis with post hoc Tukey’s HSD test).
The slow recovery kinetics of ES cells 2 hours after 2i/LIF withdrawal
show a significant increase when compared with ES cells in 2i/LIF (Figure
3.3B). This suggests an opening of the chromatin structure which may be
instrumental in facilitating global chromatin remodelling as cells exit naive
pluripotency and transit to the formative phase prior to lineage commitment.
The fast dynamics of H2B-eGFP recovery show no statistically significant
di↵erence across the timecourse (Figure 3.3A). This is consistent with the
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hypothesis that it represents a freely di↵using pool of H2B-eGFP which
would have the same kinetic profile regardless of cell state. This assumption
might be questionable in genomes that are heavily dominated with hete-
rochromatin, where free di↵usion would be more sterically hindered; how-
ever, chromatin is much more open in ES cells when compared with somatic
cells.
3.2 Hypotheses and goals
One of the major challenges encountered during the FRAP experiments de-
scribed in Section 3.1 was that the shape of the bleached region would de-
form, which would render a large fraction of the data unusable. An example
is shown in Figure 3.4 which compares the nucleus just after bleaching and
600 seconds later. It was obvious that some of the nuclei were undergoing
significant changes in shape as a results of dynamic forces acting on the
nucleus and that this was resulting in chromatin flowing in the nucleus.
• The first goal of this project was to understand how forces are gen-
erated and transmitted to the nucleus. We decided that the best ap-
proach was to characterise and quantify nuclear shape changes, which
act as a proxy for the forces acting on the nucleus. We were interested
in exploring whether nuclear shape changes are random, or possess de-
fined periods of oscillation, and to examine the relationship between
movements in the nuclear envelope and local changes in the cytoskele-
ton.
• The second goal was to find ways of perturbing the forces that are
transmitted through the cytoskeleton and nuclear envelope and acting
directly on chromatin. We hoped to achieve this by targeting compo-
nents in both the cytoskeleton and the nuclear envelope. We wished
to explore the role that forces acting on the nuclear envelope might
be playing in modulating the interactions between peripheral hete-
rochromatin and the nuclear lamina - in particular, to see whether
the distributions of the repressive histone modifications H3K9me2 and
H3K27me3, required for tethering chromatin to the nuclear envelope,
are mechanosensitive.
• The final goal was to determine whether altering forces propagated
to chromatin have an impact on the ability of ES cells to exit the
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naive pluripotent state and to di↵erentiate. We hypothesised that
by either reducing the forces experienced by chromatin at the nuclear
envelope (reducing nuclear shape changes) or increasing the strength of
tethering between heterochromatin and the nuclear lamina, we would
impair the ability of ES cells to access lineage specific genes enriched
at the nuclear periphery and consequently reduce the e ciency of, or
block, di↵erentiation.
Figure 3.4: Nuclear shape changes deform chromatin. FRAP of
H2B-eGFP. Panels outline FRAP series with pre-bleach, post bleach, 300
and 600 seconds post bleach. The bleached region is highlighted in white
and deforms during the timecourse as the nucleus changes shape.
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Chapter 4
Actomyosin drives nuclear
shape changes
In this Chapter I outline the work that we have done to characterise nuclear
shape changes in mouse ES cells and to determine how they are driven.
Before the experiments that were conducted are introduced and discussed I
explain the methodology behind our analysis of quantifying the amplitude
of nuclear shape changes.
4.1 Quantification of magnitude of nuclear shape
changes
There are a number of ways that shape changes can be quantified, all of
which have their advantages and disadvantages. I have, primarily, chosen
two methods to calculate the magnitude of the shape changes. The first
method looks at the absolute area di↵erences between images as a function
of their frame separation, n. The method is highlighted below in Figure 4.1.
31
t = t0 t = t0+n t = t0+2n
I(t0) I(t0+n) I(t0+2n)
|I(t0+2n)-I(t0+n)||I(t0+n)-I(t0)|
H2B-eGFP
(1) Threshold to binary
(2) Subtract images and take absolute value
(3) Take sum of remaining
 white pixels and normalise
 to perimiter length.
(4) Shape change magnitude for 
image frame separation n given by
 averaging over t (from t0...tL-n)
5μm
Figure 4.1: Method A of nuclear shape change quantification.
Method A relies on taking the absolute di↵erence, in pixels, between im-
ages of ES cell nuclei as a function of image/frame separation. The resulting
shape change magnitude provides information of global shape changes at all
timescales, but cannot provide any information of fluctuations in the nuclear
boundary.
The first step is to threshold the video of the nucleus to create binary
images. The absolute di↵erence between images separated by n frames is
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then calculated - the sum of the remaining non-zero pixels - and normalised
by the length of the nuclear perimeter. These values are then averaged over
time, from t = 0 to L n, where L is the total number of images, to give the
nuclear shape change magnitude as a function of n - summarised in equation
4.1.
Magnituden =
L nP
t=0
⇣
abs(Imaget   Imaget+n)
Perimetert
⌘
L  n (4.1)
The advantages of this method are that it can deal with a nucleus of any
shape and that it gives a measure of how the shape changes over both short
(low n) and long (high n) timescales. The downside of this method is that,
by using a global approach, it cannot provide any information about local
fluctuations in the nuclear envelope.
The second method, which looks at the fluctuations in the radial position
of the nuclear boundary, is summarised below in Figure 4.2.
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Figure 4.2: Method B of nuclear shape change quantification.
Method B looks at the fluctuations in the radial position of the nuclear
boundary. Nuclear shape change magnitude is given by taking the standard
deviation of the radial nuclear boundary coordinate at angle theta, averaged
over all angles. This method gives information about the size of fluctua-
tions in the nuclear boundary, but it not robust to analysing nuclei with odd
shapes.
First, using the centroid of the first image as the centre of the new
coordinate system, the coordinates of the nuclear boundary are converted
from Cartesian coordinates into polar coordinates using linear interpolation.
Second, the boundary coordinates, now plotted as radius (R) vs. angular
coordinate (✓), are detrended so that the average radial value is zero - this
normalises for any di↵erences in the size of the nucleus and also controls for
any small fluctuations of the focal plane in the z-axis. The magnitude of the
shape changes is then given as follows in equation 4.2, where L is the total
number of images and N is the total number of ✓ values in each image:
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Magnitude =
2⇡P
✓=0
 r
LP
t=1
(Rt,✓)
2
/L
!
N
(4.2)
This analysis has the advantages that it provides a single value that rep-
resents the magnitude of the nuclear shape changes, controls for nuclear size
and focal plane drift, and provides the basis for more complicated analyses
of the fluctuations in the nuclear envelope (to be discussed in further detail
later). It cannot, however, be used to analyse nuclei which have odd shapes
where the position of the nuclear envelope in polar coordinates can become
multivalued (i.e. the centroid of a bean-shaped nucleus can lie outside of the
nucleus).
4.2 The cytoskeleton and nuclear shape changes
Shape changes necessitates motion and motion necessitates forces. In Section
1.4 I discussed how tension is necessary for the propagation of forces through
the cytoplasm to the nucleus and that this tension is largely generated by
the action of molecular motors, notably non-muscle myosin II, and the poly-
merisation of actin. In order to explore this we chose to use small molecules
to inhibit the action of non-muscle myosin II (Blebbistatin and Y27632) and
to promote polymerisation and stabilisation of actin (Jasplakinolide) in E14
Tg2a mouse ES cells cultured in 2i/LIF, which we hypothesised would re-
duce the magnitude of the nuclear shape changes. The inhibitor, Nocodazole,
which targets microtubule polymerisation was also included as microtubule
polymerisation forces have been implicated in driving nuclear fluctuations
in the literature (Hampoelz et al. , 2011)(Schreiner et al. , 2015). The re-
sults are shown in Figure 4.3 where the magnitude of nuclear shape changes,
quantified using the first method (A) and second method (B) outlined in
Section 4.1 respectively, are significantly reduced when treated with Bleb-
bistatin, Y27632 and Jasplakinolide. Figure 4.3A indicates that treatment
with Nocodazole may increase nuclear shape changes, although the exper-
iment lacks the statistical power to detect any significant di↵erence in the
means between control and Nocodazole treatment in Figure 4.3B.
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Figure 4.3: Perturbation of nuclear shape change with small
molecule inhibitors. Caption continued on following page.
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Figure 4.3: E14 Tg2a ES cells in 2i/LIF treated with 10 µM Blebbis-
tatin, 10 µM Y27632, 150 ng/ml Jasplakinolide and 500 ng/ml Nocodazole.
Nuclei visualised after 45 min incubation with 2 µM SiR-Hoechst. (A) Mag-
nitude of nuclear fluctuations calculated with equation 4.2. Solid line and
shaded area represent the mean and standard deviation, respectively. Block-
ing the action of non-muscle myosin IIA with Y27632 and Blebbistatin, or
stabilising the polymerisation of actin with Jasplakinolide suppresses nuclear
shape changes. De-polymerising the microtubule network with Nocodazole
enhances nuclear shape changes. (B) Subtracted nuclear area as a function
of incremental frame separation, calculated using equation 4.1. Analysis
of nuclear boundary fluctuations shows significantly reduced nuclear shape
changes when inhibiting non-muscle myosin IIA and stabilising actin poly-
merisation. Statistical analysis was performed in MATLAB using a one-way
ANOVA followed by a multi-comparison test. Samples with di↵erent let-
ters show significant di↵erences at the five percent confidence level, whereas
those with the same letter do not.
4.3 Fluctuations in cortical actin intensity and the
nuclear envelope
The data in the previous section confirms that actin and myosin are required
for propagating forces to the nucleus and driving nuclear shape changes. To
take this further we wished to investigate the relationship between the poly-
merisation of actin and the dynamics of the nuclear envelope in more detail.
To achieve this, we used the H2B-eGFP mouse ES cell line and stably trans-
fected it with LifeAct-RFP. LifeAct is a small peptide (17 amino acids) that
binds selectively to filamentous (F-) actin, dissociates when F-actin is dis-
assembled into monomeric form, and does not interfere with polymerisation
dynamics (Riedl et al. , 2010), and has been fused to a red fluorescent protein.
Figure 4.4A depicts a thin optical slice through the nucleus of a H2B-eGFP
LifeAct-RFP ES cell. Strikingly, the F-actin is primarily localised in a thin
band that underlies the cell membrane known as the cortex.
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Figure 4.4: Localisation of the nuclear boundary and cortical actin.
(A) Optical slice through the centre of an H2B-eGFP LifeAct-RFP mouse ES
cell, taken with an Andor Revolution XD spinning disk confocal with a 63x
1.4NA objective. Actin, predominately localised to the cortex, in red and the
nucleus in green. (B) Custom MATLAB script to extract the position of the
nuclear boundary in polar coordinates (RN (✓, t)). (C) Custom MATLAB
script to extract cortex position (RC(✓, t)) and intensity (IC(✓, t)), with the
position of the nuclear boundary shown in white for reference.
Using an Andor Revolution XD spinning disk confocal with a 63x 1.4
NA objective we took live images through the centre of the nucleus of H2B-
eGFP LifeAct-RFP cells cultured in 2i/LIF. Thirty images were captured
with an eight second interval and laser intensity was kept as low as possi-
ble to avoid phototoxicity and to minimise bleaching. In order to analyse
the data, the images were first imported into ImageJ and split into sepa-
rate channels (nucleus and cortex) where the multistackreg plugin was used
to remove any translation or rotation of the nucleus during the timecourse.
The same transformations were then applied to the images of the cortex.
Videos of individual nuclei and cortical actin were then loaded into MAT-
LAB and analysed using a custom script: using the centroid of the nucleus
from the first frame of the time series as a reference, the images of the nu-
cleus and cortex were transformed into polar coordinates. The coordinates
of the nuclear boundary, shown in Figure 4.4B in black, were then identi-
fied and extracted. The analysis of the cortex, shown in Figure 4.4C, was
more complicated: cortical position and width were measured by fitting a
Gaussian in every angular bin. The centre of the Gaussians were used as
the radial coordinates of the cortex, shown in black, and cortical thickness
38
was taken as plus and minus one standard deviation (red lines). The angu-
lar cortical intensity was calculated as the mean pixel value of the top five
highest intensity pixels contained within the red lines. The position of the
nuclear boundary is shown in white for reference.
To start with, we employed Fourier analysis to determine whether there
were any dominant frequencies of oscillation in both cortical actin intensity
and nuclear envelope position. The analysis was conducted on H2B-eGFP
cells cultured in 2i/LIF. We also chose to supplement the cells with 5 µM
Blebbistatin in order to reduce the forces propagated to the nucleus and
determine what e↵ect this had on the frequencies of oscillation. Local cortical
intensity and nuclear boundary positions were first detrended over time (with
a constant), multiplied with a Hanning window1 and then zero padded2. The
Fourier transforms were then averaged over all ✓ and then over all cells. The
results in Figure 4.5 show that both the nuclear boundary and cortical actin
intensity possess a dominant low frequency oscillation, centred on 0.0045
Hz, which corresponds to a period of just over 200 seconds. Treatment with
5 µM Blebbistatin results in a drop in the amplitude of nuclear boundary
fluctuations as expected; however, as the dominant low frequency mode is
still present, it is likely that the cytoskeleton and nucleus are not completely
decoupled.
1The Hanning window is a window function designed to tackle the finite nature of the
sampling in the time domain. Multiplication by the Hanning window ensures that there is
no discontinuity when the beginning and end of the signal are joined together due to the
circular topology of the Fourier transform. If the discontinuity were present, the Fourier
transform would be corrupted by both high and low (aliased) frequency components.
2Zero padding is the process of artificially increasing the length of the time domain
signal by adding zeros to the end of signal before taking the Fourier transform. This
increases the number of frequency bins which aids in localising isolated frequencies, but
does not alter the resolution.
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Figure 4.5: Fourier analysis of cortical actin intensity and nuclear
boundary fluctuations. Frequency spectrum of cortical actin intensity
(A) and radial nuclear boundary position (B) in H2B-eGFP mouse ES cells
cultured 2i/LIF. Fourier analysis conducted using a Hanning window and
detrended (constant value) data. Solid line and shaded area represent the
mean and standard deviation, respectively. A dominant low frequency os-
cillation is present - centred on 0.0045 Hz in both plots. Treatment with 5
µM Blebbistatin significantly dampens the magnitude of nuclear boundary
fluctuations but does not remove the dominant frequency of oscillation.
To take this one step further and see whether there is a relationship
between local fluctuations in cortical actin intensity and the movement of
the nuclear boundary directly radially inward, we took cross-correlations of
the intensity of actin in the cortex with both the position of the nuclear
boundary and the separation between the nuclear boundary and the cortex.
A schematic of the variables involved is shown below in Figure 4.6.
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Figure 4.6: Schematic of variables in the cross correlation analysis
of cortical actin and nuclear boundary. The variables are: cortical
actin intensity (1) IC(✓, t), separation of cortex and nuclear boundary (2)
SNC(✓, t) = RC(✓, t) RN (✓, t) and nuclear boundary position (3) RN (✓, t).
The results are shown in Figures 4.7A and 4.7B for H2B-eGFP LifeAct-
RFP cells cultured in 2i/LIF and in Figures 4.7C and 4.7D for H2B-eGFP
LifeAct-RFP cells cultured in 2i/LIF supplemented with 5 µM Blebbistatin.
In both cases, we chose to separate the data set and distinguish between cells
that were blebbing ((B) and (D)), and those that weren’t ((A) and (C)), the
reasons for which will be explained later below. The cross-correlations all
possess a dominant oscillatory frequency; this is expected as we have already
shown that both cortical actin intensity and the position of nuclear bound-
ary fluctuate with similar periods (Figure 4.5). The key result, however, is
that the local fluctuations in cortical actin intensity and the position of the
nuclear boundary underneath are out of phase by ⇡ radians - Figure 4.7A, in
green. By comparing the cross-correlations of the cortex with the position of
the nuclear boundary and the cortex with the separation of the cortex and
nuclear boundary it is possible to discern how the positions of the nucleus
and cortex are changing with respect to one another. The separation, shown
above as variable (2) in Figure 4.6, is defined as the position of the nucleus
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boundary subtracted from the position of the cortex. If the cortex remains
static, the separation is the negative of the nuclear boundary which, when
comparing cross-correlations of both variables with the intensity of actin in
the cortex, would result in the cross-correlations being the reflection of one
another in the y-axis at zero o↵set. This is what is seen in Figures 4.7(C)
and 4.7(D) where the cells have been treated with Blebbistatin. We can
therefore infer that suppressing the action of non-muscle myosin II does not
alter the frequency of oscillations in cortical actin intensity but does signifi-
cantly reduce any movement of the cortex to an amplitude below that of the
fluctuations in the nuclear boundary. Figures 4.7A and 4.7B show the oppo-
site trend: the cross-correlations (blue vs. green) are remarkably similar to
one another. This implies that the fluctuations in the local positions of the
cortex and the nuclear boundary with respect to the centre of the nucleus
are in phase with one another, with movements in the cortex being greater in
amplitude. Support for these inferences is given in Figure 4.8A by checking
that the cross-correlations of cortical and nuclear positions are in phase in
2i/LIF conditions and out of phase when treated with 5 µM Blebbistatin.
Blebbing represents a significant source of bias in this analysis. Blebbs
are thought to arise from hydrostatic pressure created by actomyosin con-
tractility in the cell. A local weakening in the cortex results in the uncoupling
of the cortex from the cell membrane and a reduction in hydrostatic pres-
sure as cytoplasm flows in to create the blebb. Blebb expansion stops when
membrane tension in the blebb balances out the hydrostatic pressure. The
cortex is then reassembled under the plasma membrane in the blebb and
actomyosin contractility subsequently leads to its collapse. With regards to
the analysis above, a blebb represents a significant increase in the local nu-
clear boundary/cortex separation, followed by an increase in actin intensity.
This e↵ect dominates the cross-correlation between cortical actin intensity
and the separation of the nuclear boundary and the cortex, shown in Fig-
ure 4.7B - where separation between cortex and nuclear boundary leads the
oscillations ⇡/2 out of phase with cortical actin intensity. The data sets
were therefore separated into blebbing and non-blebbing populations to try
to minimise this e↵ect and prevent it from biasing the analysis.
42
Figure 4.7: Cross-correlations between local position and intensity
of cortical actin and the position of the nuclear boundary radially
inwards. Each plot contains the cross-correlation between cortical actin
intensity and the separation of the nucleus and cortex (blue) and between
cortical actin intensity and position of the nuclear boundary (green) in H2B-
eGFP LifeAct-RFP mouse ES cells cultured in 2i/LIF. The cross-correlations
are first calculated in angular sections and averaged to give a trace for each
cell. Solid line and shaded area represent the mean and standard deviation,
respectively, between cells. (A) Cross-correlations in non-blebbing cells show
cortical actin intensity fluctuates pi out of phase with the position of the nu-
clear boundary. (B) Cross-correlation in blebbing cells shows large magni-
tude (blue) indicating analysis sensitive to blebbs. (C) Cross-correlations in
non-blebbing Blebbistatin treated cells. (D) Cross-correlations in blebbing
Blebbistatin treated cells.
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Figure 4.8: Cross-correlation between the local position of cortical
actin and the position of the nuclear boundary radially inwards.
Analysis conducted in H2B-eGFP LifeAct-RFP mouse ES cells cultured in
2i/LIF. The cross-correlation is calculated at each angular section and then
averaged to give a trace for each cell. Solid line and shaded area represent
the mean and standard deviation, respectively, between cells. (A) Cross-
correlation in non-blebbing cells. (B) Cross-correlation in non-blebbing cells
treated with 5 µM Blebbistatin. The correlations show that the radial posi-
tions of the nuclear boundary and the cortex move in phase with one another.
4.4 Discussion
We have shown in Figure 4.3 that components of the actomyosin cytoskele-
ton are involved in driving nuclear shape change. Inhibiting the action of
non-muscle myosin II or promoting the polymerisation of actin both lead to
a significant reduction in the amplitude of nuclear shape changes. We also
found inhibition of microtubule polymerisation led to a possible, but not
statistically significant, increase in the amplitude of nuclear shape changes.
Our findings agree with a prior study, which compared nuclear area fluctua-
tions in mouse ES cells with primary mouse embryonic fibroblasts (PMEFs)
- a di↵erentiated cell type (Talwar et al. , 2013). The authors found that
microtubule dynamics had no impact on nuclear area fluctuations in ES
cells (Nocodazole treatment) and that depolymerising actin stress fibres in
PMEFs increased nuclear area fluctuations to an amplitude comparable with
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ES cells. The authors concluded that the presence of an actin stress fibre
network in PMEFs, lacking in ES cells where F-actin is constrained to the
cortex (Figure 4.4), was stabilising the nucleus against fluctuations. The
study did not, however, explore the origin of the driving forces of ES cell
nuclear fluctuations, which we have sought to address in this study.
There are a couple of possible mechanisms that explain our results.
Firstly, inhibition of non-muscle myosin II would result in a loss of cytoskele-
tal tension and the inability to transmit forces through the cytoskeleton
and the LINC complex to the nucleus. Additionally, the magnitude of the
forces generated within the cytoskeleton by actomyosin contractility would
be significantly reduced. If the polymerisation of actin is promoted and the
filaments stabilised, while the cells would be capable of generating and trans-
mitting forces through their cytoskeleton to the nucleus, the distribution of
these forces are likely to be much less dynamic. Both scenarios would lead
to a sharp reduction in nuclear shape changes.
As second explanation is that actomyosin contractility is generating a
fluid flow in the cytoplasm that exerts dynamic pressure on the nucleus. In
a study by Kumar et al. (2014), the authors found that a hydrodynamic
approach could be used to describe observed rotations in the nuclei of fi-
broblast cells (NIH3T3). They found that nuclear rotation correlated with
a hydrodynamic flow of actin around the nucleus and that the speed and
coherence of the rotations were significantly reduced by lowering actomyosin
contractility with blebbistatin treatment. Stabilising the polymerisation of
actin filaments and lowering cytoskeletal stress through inhibition of non-
muscle myosin II could therefore dampen nuclear shape changes by reducing
this flow of fluid.
The observation that treatment with the microtubule depolymerising
drug Nocodazole may result in an increase in nuclear shape changes when
compared with controls (Figure 4.3A) is consistent with the fact that disas-
sembly of the microtubule network is known to increase actomyosin contrac-
tility (Danowski, 1989) - this process is mediated through activation of RhoA
GTPase and subsequent increase in the assembly of actin-myosin contractile
filaments (Chang et al. , 2008). It is worth noting that, while microtubule
dynamics do not drive nuclear shape changes in mouse ES cells, studies per-
formed in the early Drosophila embryo have identified microtubule dynamics
as the driving force of nuclear envelope fluctuations (Hampoelz et al. , 2011).
The fluctuations in the nuclear envelope are not random - they have a
well-defined period of approximately 200 seconds which coincides with the
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timescale of oscillations in the intensity of cortical actin (Figure 4.5). A
similar period of fluctuation, centred on 140 seconds, has also been observed
in fluctuations of ES cell nuclear area (Talwar et al. , 2013). Our result,
in conjunction with the correlations between the local intensity of cortical
actin and the position of the nuclear boundary radially inward (Figure 4.7),
provides strong evidence that cortical actin and the nucleus are mechanically
coupled. The observation that the intensity of cortical actin fluctuates ⇡
radians out of phase with, and ahead of, the nuclear boundary could be
explained by hysteresis in the system: the build-up and dissipation of non-
muscle myosin II may follow, but lag, the fluctuations in cortical actin.
This could explain why the forces on the nucleus are out of phase with the
intensity of cortical actin.
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Chapter 5
Nuclear envelope proteins
influence nuclear shape,
dynamics and chromatin
structure
In this Chapter I introduce the perturbations of our in vitro mouse embryonic
stem cell system and outline what we hoped to achieve with them. I then
present the data and the results of our analysis into their characterisation.
5.1 Perturbing the forces on chromatin and the
regulation of peripheral heterochromatin
Our goal is to explore whether forces acting on the nucleus are important for
facilitating changes in gene expression during the exit from naive pluripo-
tency and linage specification in mouse ES cells. Our hypothesis is that
forces acting on the nuclear envelope may facilitate transitions between tran-
scriptional states during di↵erentiation through the bulk movement of chro-
matin in the nucleus as a result of global nuclear shape changes, or the
re-organisation of nuclear lamina/LAD contacts driven by local fluctuations
in the nuclear envelope. To test whether this is the case, we set out to
accomplish the following with our perturbations:
1. To modulate the magnitude of the forces that are transmitted directly
to chromatin.
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2. To modulate the strength of the tethering between peripheral hete-
rochromatin and the nuclear envelope.
The first perturbation targets force generation in the cytoskeleton through
treatment with the small molecular inhibitor Blebbistatin, which acts as a
highly selective inhibitor of non-muscle myosin II. We have demonstrated, in
Chapter 4, that the magnitude of nuclear shape changes can be significantly
reduced by treatment with 10 µM Blebbistatin, indicative of a reduction in
the forces transmitted to the nucleus. We believe this is a result of not only
inhibiting force generation in the cytoskeleton, but also removing the ability
to propagate any forces to the nucleus due to lack of cytoskeletal tension -
as discussed in Section 1.4.
The other perturbations modify the structure of the nuclear envelope and
nuclear lamina through overexpression and, where appropriate, knockdown
of key structural proteins designed to either modulate forces transmitted to
chromatin, or alter the strength of heterochromatin tethering at the nuclear
envelope.
The second perturbation is the overexpression of LMNA. LMNA has been
shown to sti↵en and bu↵er the nucleus against external forces (Pajerowski
et al. , 2007) and act as an anchor for tethering peripheral heterochromatin
to the nuclear lamina (Solovei et al. , 2013). LMNA is not thought to be
expressed in ES cells (Constantinescu et al. , 2006) although this fact has
been disputed by Eckersley-Maslin et al. (2013) who have found LMNA
expressed at low levels. We hoped that sti↵ening the nucleus and increasing
heterochromatin binding at the nuclear envelope would act in a synergis-
tic way to reduce the movement of chromatin at the nuclear envelope and
restrict access to genes bound there.
The third perturbation is the overexpression and knockdown of lamin
B receptor (LBR). LBR has been identified as acting as the primary hete-
rochromatin tether in ES cells, which lack the LMNA tether (Solovei et al.
, 2013). We hoped that overexpressing LBR would increase the strength of
peripheral heterochromatin tethering and restrict access to any genes bound
there, resulting in a decrease in plasticity, while knockdown of LBR would
have the opposite e↵ect.
The final, fourth, set of perturbations are the overexpressions of trun-
cated KASH domain proteins, shown below in Figure 5.1. The vectors
used were a kind gift from the lab of G.W. Gant Luxton (Luxton et al.
, 2011). The truncated KASH domain proteins, mRFP-KASH and mRFP-
48
SR-KASH, when overexpressed, act as dominant negatives for the endoge-
nous Nesprins - outcompeting them for binding to the SUN proteins. The
result is that the LINC complex is broken and the nucleus and cytoskeleton
become decoupled at the outer nuclear membrane, while any unwanted per-
turbations to chromatin interactions with the nuclear lamina at the inner
nuclear membrane are minimised. The protein mRFP-KASH L possesses
a truncated KASH domain and therefore, as it cannot bind to the SUN
proteins, acts as a negative control.
mRFP
Spectrin repeat
KASH domain
Transmembrane domain
mRFP-SR-KASH
mRFP-KASH
mRFP-KASHΔL
6275 6885
6807
6807
6885
6862
mRFP
mRFP
Figure 5.1: Constructs to decouple the nucleus and the cytoskele-
ton. Truncated human Nesprin-2 (SYNE-2) KASH domain containing pro-
teins which, when overexpressed, are designed to outcompete endogenous
Nesprin binding to the inner nuclear membrane bound SUN proteins and
decouple the nucleus from the cytoskeleton at the outer nuclear membrane.
mRFP-SR-KASH and mRFP-KASH act as dominant negatives to SYNE-2.
mRFP-KASH L, which possesses a truncated KASH domain and is unable
to bind the SUN proteins, acts as the control. The proteins are based on
human SYNE-2. Figure from G.W. Gant Luxton.
The proteins in Figure 5.1 are truncated forms of human Nesprin-2
(SYNE-2). The KASH domain amino acid sequence in humans, however,
is almost identical to the sequence in mice with one amino acid substituted
from glutamate to aspartate. There should therefore not be a problem with
specificity as aspartic and glutamic acid are almost identical chemically. Un-
fortunately, due to time constraints, the KASH construct overexpressing ES
cells have not been fully characterised and the results obtained from them
will therefore be discussed separately in the final Chapter.
5.2 Inducible overexpression with the tetracycline-
controlled transcriptional activation system
To overexpress our LMNA, LBR and KASH constructs in an inducible fash-
ion we decided to use the tetracycline-controlled transcriptional activation
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system, specifically, the derivative in which transcription is activated in the
presence of a tetracycline - referred to as the Tet-On system. A schematic
of the Tet-On system, which is based upon the interaction between two
complementary control circuits, is shown in Figure 5.2 below:
Figure 5.2: Schematic of the tetracycline-controlled transcrip-
tional activation system (Tet-On). In the presence of doxycycline
(+Dox) the transcription factor rtTA can bind to the tetO elements in the
synthetic promotor Ptet and activate transcription of the gene of interest.
When doxycycline is removed, the rtTA dissociates from the promotor re-
gion and transcription of the gene of interest is halted.
The Tet-On system requires the stable integration of two plasmids into
the genome. The first plasmid encodes for, and constitutively expresses, the
transcription factor rtTA. The second plasmid contains a synthetic promotor
(Ptet) that responds to the binding of rtTA and the gene of interest. Ptet is
formed of seven tetO sequences followed by a minimal CMV promotor. In
the absence of rtTA binding, transcription of the gene of interest is silenced.
For rtTA to bind to the tetO sequences, it must be bound by a tetracy-
cline; addition of the tetracycline derivative doxycycline (+Dox) initiates
transcription, mediated by rtTA promotor binding. Subsequent removal of
doxycycline leads to rtTA dissociating from the promotor region and gene
silencing. The vector that contains the Tet-On system used for this study -
PB-TAP IRI - was a kind gift of the Silva lab (Dos Santos et al. , 2014) and
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was cloned into using the Invitrogen™ Gateway™ cloning system.
5.3 Validation of the perturbations
The first perturbation is treatment with the small molecule inhibitor of
myosin II activity - Blebbistatin - which causes embryonic stem cell colonies,
that possess tight cell-cell junctions when cultured in 2i/LIF, to break apart
where they then favour attachment to the (2D) substrate. Figure 5.3, shows
an example of this. In (A) the cells are bound tightly to one another and
individual cells cannot be identified from the bright field image. At the
boundary of the colony the nuclei are elongated under tension and com-
pression from non-muscle myosin II driven contractility in the cortex. After
treating the cells with 20 µM Blebbistatin for 10 minutes, shown in (B),
the cells have lost their strong adhesion to one another and can readily be
individually identified in the brightfield image. This is indicative of loss of
cortical tension which is known be required for stabilisation of cell-cell junc-
tions (Miyake et al. , 2006). Loss of actomyosin contractility and the release
of intracellular tension leads to the cell and nucleus relaxing into a spherical
shape - an example of which is highlighted in green.
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Figure 5.3: Reducing cytoskeletal tension breaks cell-cell junctions
and alters nuclear morphology.(A) H2B-tomato mouse ES cell cultured
in 2i/LIF. (B) H2B-tomato mouse ES cell cultured in 2i/LIF 10 minutes after
the addition of 20 µMBlebbistatin. The nuclear channel highlights the forces
on nuclei at the periphery of the colony, compressing and elongating them.
Inhibition of actomyosin contractility causes cell-cell junctions to break and
increases nuclear circularity.
The second perturbation is the inducible overexpression of the full tran-
script encoding mouse Lamin A. Figure 5.4A shows an immunofluorescence
(IF) stain of an ES cell colony stained for LMNA and LMNB1 in the induced
(+Dox) LMNA overexpression polyclonal line in 2i/LIF. First, because the
line is polyclonal, there is a large range in expression levels of LMNA and
not all the cells express it at detectable levels by IF. This was addressed by
subcloning the population and picking clones, one of which was used for all
future experiments. The clone was chosen based upon possessing the follow-
ing characteristics: exhibiting the correct morphology in 2i/LIF (compact
colonies), overexpressing LMNA at a reasonable level when induced, and not
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expressing low quantities of LMNA (leaking) when not induced. Secondly,
as expected, LMNA localises to the nuclear envelope where it forms a ring
- Figure 5.4B shows an expanded view of the nuclear envelope where DNA
has been counterstained for using Hoechst33342. Interestingly LMNA and
LMNB1 are not homogeneously distributed, but rather juxtapositioned in
the network forming the nuclear lamina - an observation that is consistent
with the literature (Swift et al. , 2013).
Lamin B1
Lamin A
Merge
DNA
KEY
(A) LMNA OE 2i/LIF +Dox (B) Distribution of lamins 
10 μm
Figure 5.4: LMNA correctly localises to the nuclear periphery. (A)
Immunofluorescence of induced (+Dox) polyclonal LMNA overexpressing
mouse ES cells, cultured in 2i/LIF and stained for LMNA (red) and LMNB1
(green). (B) Highlights the juxtapositioning of LMNA and LMNB1 at the
nuclear envelope. Images taken using a Leica SP5 confocal microscope with
a 63x 1.4 NA oil immersion objective.
The third perturbation is the inducible overexpression of LBR. Upon
induction with doxycycline we expected to find an enrichment of LBR at the
nuclear lamina; instead we found that nuclear architecture was significantly
altered. Figure 5.5 shows the clonal LBR ✏ line after 24 hours in N2B27. The
doxycycline treated cells exhibit aberrant nuclear shapes, when compared
with controls, with LBR distributed throughout the nucleus where it forms
lamina like structures. The organisation of heterochromatin was also a↵ected
with a shift in organisation from distinct foci to filaments. The filaments of
heterochromatin, stained with Hoechst 33342, that are most clearly shown in
Figure 5.5C overlap precisely with the distribution of LBR, shown in Figure
5.5D.
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Figure 5.5: LBR overexpression significantly perturbs nuclear
structure and the organisation of heterochromatin. (A) Immunofluo-
rescence of LBR in LBR ✏ overexpressing cells cultured for 48 hours in N2B27
without doxycycline (Control). (B) Immunofluorescence of LBR in LBR ✏
overexpressing cells cultured for 48 hours in N2B27 with doxycycline. (C)
Expanded image of (B) which shows filamentous heterochromatin upon in-
duction of LBR. (D) Image (C), but only the LBR channel. Overexpression
of LBR reorganises the distribution of chromatin from punctate foci into fil-
amentous structures which strongly correlate with the distribution of LBR.
A strong possibility is that, upon overexpression, high/excess levels of LBR
interact with heterochromatin in the nuclear interior driving assembly of
nuclear lamina like structures which perturb heterochromatin organisation.
To take this a step further we checked to see whether any proteins that
are known to interact with LBR showed a similar phenotype. The obvious
candidate was LMNB1 which, strikingly - shown by immunofluorescence in
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Figure 5.6 in LBR ✏ overexpressing cells cultured in N2B27 for 48 hours - also
forms filamentous structures within the nucleus upon overexpression of LBR.
The distribution of the filaments of heterochromatin and LMNB1 shown in
Figures 5.6C and 5.6D shows a similar degree of overlap to that of hete-
rochromatin and LBR (Figures 5.5C and 5.5D). This strongly suggests that
the overexpression of LBR is sequestering LMNB1 from the nuclear envelope
to the nuclear interior where they interact with and alter the organisation
of heterochromatin.
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Figure 5.6: LBR overexpression alters the distribution of LMNB1.
(A) Immunofluorescence of LMNB1 in LBR ✏ overexpressing cells cultured
for 48 hours in N2B27. (B) Immunofluorescence of LMNB1 in LBR ✏ over-
expressing cells cultured for 48 hours in N2B27 with doxycycline. (C) Ex-
panded version of (B), highlighting the presence of filaments of heterochro-
matin in doxycycline treated LBR ✏ overexpressing ES cells. (D) Image (C)
but showing the distribution of LMNB1. LBR overexpression causes a shift
in the distribution of LMNB1, moving it away from the nuclear envelope
into the nuclear interior where its distribution shows strong overlap with
filaments of heterochromatin.
Before moving on to examine the e↵ects of the perturbations on nuclear
shape and dynamics, because the perturbations target both force generation
and the structure of the nuclear envelope - the former which is required for
cell division and the latter which must be broken down during it - we mea-
sured the proliferation rates in ES cells overexpressing LMNA and LBR and
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treated with di↵erent concentrations of Blebbisatin - shown below in Figure
5.7. The results show that: while treatment with 5 µM Blebbistatin and
above completely blocks cell division; 2 µM has no significant e↵ect, over-
expression of LBR in the clonal ✏ line increases the rate of cellular division
by 20% (Figures 5.7B and 5.7D); and the overexpression of LMNA in the
clonal   line has no significant e↵ect (Figures 5.7C and 5.7D).
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Figure 5.7: LBR overexpression decreases proliferation rate by
20%. Overexpression of LMNA or treatment with 2 µM Blebbis-
tatin has no significant e↵ect. Assay of proliferation rates in (A) E14
Tg2a + Blebbistatin treatment, (B) LBR ✏ OE and (C) LMNA   OE mouse
ES cells in 2i/LIF. Division rates - calculated from the gradient of the best
fit lines in (A), (B) and (C) and listed in (D) - show that, while LBR overex-
pression slows down division by 20%, LMNA overexpression and treatment
with 2 µM Blebbistatin has no significant e↵ect. Treatment with 5 µM and
10 µM Blebbistatin blocks proliferation and causes significant cell death.
5.4 Cellular and nuclear morphology
In this Section I examine the e↵ect of the perturbations introduced in this
Chapter on nuclear morphology. The morphology of the nucleus is important
to characterise because it is intimately connected to, and acts as an indirect
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read-out of, the forces acting on and propagated within the cell.
To characterise the shape of the nucleus we have chosen to use the shape
descriptors defined below:
Eccentricity =
Foci Separation
Major Axis
(5.1)
An eccentricity of 0 is a circle, a value of 1 is a line segment.
Circularity = 4⇡ ⇤ Area
Perimeter2
(5.2)
A circularity of 1 is a circle, a value of 0 is a line segment.
Solidity =
Area
Convex Area
(5.3)
Eccentricity and circularity give complementary measurements of how
elliptical the nucleus is; however, because circularity uses the perimeter of the
nucleus, the measurement is sensitive to undulations in the nuclear envelope
that would otherwise be missed by eccentricity. Solidity is included to give
a measure of how much the shape of the nucleus deviates from elliptical.
Lastly, we have included projected area, which gives a measure of how spread
the nuclei are. Representative images of the e↵ect of LMNA overexpression,
LBR overexpression and LBR knockdown on nuclear shape are shown below
in Figure 5.8. Quantification of nuclear shape using the shape descriptors
discussed above are presented in Figure 5.9 and the results summarised as
follows:
• LMNA overexpression: reduces eccentricity but does not alter circu-
larity, and has no e↵ect on solidity or area.
• LBR overexpression: increases eccentricity, reduces circularity and so-
lidity, and does not alter area.
• LBR knockdown: reduces eccentricity, increases circularity and solid-
ity, and reduces area.
• Treatment with 2 µM Blebbistatin: has no e↵ect on eccentricity, in-
creases circularity and solidity, and has no e↵ect on area.
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(A) LMNA y OE Control
48hr N2B27
(B) LMNA y OE Dox
48hr N2B27
(C) LBR ε OE Control
48hr N2B27
(D) LBR ε OE Dox
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 knockdown 48hr N2B72
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knockdown 48hr N2B27
LMNA
LBR
20 μmDNA
Figure 5.8: Comparison of nuclear morphology. Nuclear mor-
phology after 48 hours in N2B27, analysed quantitatively in Figure 5.9.
(A)/(B) LMNA overexpression, (C)/(D) LBR overexpression and (E)/(F)
LBR knockdown (siRNA). 60
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Figure 5.9: Quantification of nuclear shape. Caption on following
page.
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Figure 5.9: Shape descriptors of mouse ES cell nuclei. Cells were cultured
on laminin coated (10 µg/ml) 24-well plates in N2B27 for 48 hours with the
following perturbations: overexpression of LMNA, overexpression of LBR,
LBR knockdown and treatment with 2 µM Blebbistatin. (A) Comparison
of nuclear eccentricity - equation 5.1. (B) Comparison of nuclear circular-
ity - equation 5.2. (C) Comparison of nuclear solidity - equation 5.3. (D)
Comparison of nuclear projected area. Statistical analysis was performed in
MATLAB using a Kruskal-Wallis test and a multi-comparison test. Samples
with di↵erent letters show significant di↵erences at the five percent confi-
dence level, whereas those with the same letter do not. LMNA overexpres-
sion reduces nuclear eccentricity. LBR overexpression results in elongated
and aberrantly shaped nuclei, while LBR knockdown has the opposite e↵ect,
giving smaller, and more circular, nuclei. Reduction in actomyosin tension
through non-muscle myosin II inhibition (Blebbistatin treatment) also leads
to an increase in nuclear circularity. N = 3, with n > 1000 for each cell type.
5.5 Nuclear shape change dynamics
After exploring the e↵ect of the perturbations on static nuclear morphol-
ogy, we turned our attention to looking at the dynamics of the nuclear
envelope. Using the nuclear shape change characterisation methods dis-
cussed in Chapter 4 - equations 4.1 and 4.2 - we analysed the amplitude
of nuclear shape changes in LMNA-overexpressing, LBR-overexpressing and
Blebbistatin-treated mouse ES cells cultured in N2B27 for 48 hours. We
chose to use a low concentration of Blebbistatin - 2 µM - as this was found
by titration to be the highest dose before the rate of cellular proliferation was
significantly increased (Chapter 6 - Figure 5.7). The results of the analysis
of the magnitude of nuclear shape change are shown in Figure 5.10: treat-
ment with 2 µM Blebbistatin has no significant e↵ect - (A)/(D), LMNA
overexpression reduces shape change - (C)/(D), and LBR overexpression in-
creases shape change (B). It was not possible to perform the shape change
analysis that looks at fluctuations in the nuclear boundary, shown in Figure
5.10D, in LBR-overexpressing cells because a significant fraction of the cells
yielded radial nuclear boundary coordinates (as a function of angle) that
were multivalued due to aberrant nuclear shape.
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Figure 5.10: LMNA overexpression reduces nuclear shape change,
LBR overexpression increases it. Analysis of dynamics of nuclear shape
change of LBR & LMNA overexpression and treatment with 2 µM Blebbis-
tatin in E14 Tg2a ES cells after 48 hrs in N2B27, using equation 4.1 in
figures (A-C) and equation 4.2 in figure (D). (A-C) - solid line and shaded
area represent the mean and standard deviation, respectively. E14 Tg2a
Control: n = 84, E14 Tg2a + 2 µM Blebbistatin: n = 74, LBR ✏ Control:
n = 75, LBR ✏ +Dox: n = 77, LMNA   Control: n = 118, LMNA   +Dox:
n = 89. Statistical analysis performed in MATLAB using a Kruskal-Wallis
test, followed by a multi-comparison test. (D) p < 0.05 shown by asterisk.
The next stage of the project was to characterise the frequency spectrum
of the fluctuations in the nuclear boundary with the perturbations. In order
to increase the throughput in our experiments we lowered the magnification
in our imaging compared with experiments referenced in Chapter 4, switch-
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ing from a 63x 1.4 NA to a 40x 1.2 NA oil immersion objective. While this
allowed us to image significantly more cells and increase our population sam-
pling rate, it exacerbated the problem of the discrete nature of the images.
This is summarised in Figure 5.11: Figure 5.11B illustrates an example of
the fluctuation in the radial position, in pixels, of a point on the boundary
of the nucleus over time. When using a thresholding method for detecting
the nuclear envelope, depicted in blue, it results in significant high frequency
fluctuations as the boundary oscillates between pixels. Correspondingly the
resultant Fourier transform, shown in Figure 5.11A in blue, is corrupted by
a broad range of frequencies that, while unable to mask the dominant low
frequency oscillation, removes any high frequency information. In order to
combat this, we took advantage of the fact that the pixels in the image are
blurred by the point spread function (PSF) of the microscope, the form of
which is known to be a Gaussian. By fitting a Gaussian to the radial in-
tensity across the nuclear boundary (Figure 5.11D), we can obtain sub-pixel
resolution of the localisation of the nuclear envelope, shown in Figure 5.11B
in red. As a result the majority of the high frequency noise in the Fourier
transform, Figure 5.11A - red, is removed.
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Figure 5.11: Obtaining sub-pixel localisation of the nuclear bound-
ary improves Fourier analysis. (A) Using a Gaussian fit of the nuclear
boundary significantly reduces high frequency corruption of the FFT that
results from identifying nuclear boundary based on threshold value. (B) Sub
pixel localisation of point on nuclear boundary obtained with Gaussian fit.
(C) Polar plot of nuclear boundary fit with threshold method and Gaussian
fit. (D) Example fit of Gaussian to radial pixel intensity across the nuclear
boundary.
We applied the improvements to our Fourier analysis to look at the fre-
quency spectrum of oscillations in the nuclear envelope in LMNA-overexpressing
and Blebbistatin-treated E14 Tg2a mouse ES cells, cultured in N2B27 for 48
hours. The results, shown below in Figure 5.12, show a dominant period of
oscillation centred on 0.0045 Hz with no significant di↵erence when LMNA
is overexpressed, or the cells are treated with 2 µM Blebbistatin.
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Figure 5.12: Overexpression of LMNA or treatment with 2 µM
Blebbistatin does not alter the Fourier spectrum of nuclear shape
change. Fourier analysis of nuclear shape change in E14 Tg2a supplemented
with 2 µMBlebbistatin and LMNA   overexpressing mouse ES cells, cultured
for 48 hrs in N2B27. Fourier analysis conducted using a Hanning window
and detrended (constant value) data on fluctuations in radial boundary co-
ordinates, averaged over all angles and then over all cells. Solid line and
shaded area represent the mean and standard deviation, respectively. E14
Tg2a Control: n = 84, E14 Tg2a + 2 µM Blebbistatin: n = 74, LMNA  
Control: n = 118, LMNA   +Dox: n = 89.
This Chapter has focused, so far, on characterising the e↵ect of the forces
acting on the nucleus and introducing ways in which to perturb these forces.
We have measured the impact on both nuclear morphology and nuclear shape
change dynamics - magnitude and frequency. In the next part of the Chap-
ter we explore to what extent the perturbations modulate the interactions
between heterochromatin at the nuclear periphery and the nuclear envelope.
As a read-out, we chose to look at the distributions of epigenetic modifi-
cations that are required for regulating these interactions, the specifics of
which are discussed in the next section. In particular, we expected to find
the overexpression of LMNA and LBR - both implicated as chromatin teth-
ers (Solovei et al. , 2013) - would result in an enrichment of repressive histone
modifications at the nuclear periphery during di↵erentiation as, we hypoth-
esised, the cells would struggle to release and access any lineage genes stuck
there.
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5.6 Distribution of repressive histone modifications
In this section I look at the distribution of repressive histone modifications
in the pluripotent ground state and during di↵erentiation. We chose to
look at histone 3 lysine 9 di-methylation (H3K9me2) and histone 3 lysine
27 tri-methylation (H3K37me3) for two reasons. Firstly, these repressive
histone modifications are implicated in the positioning of peripheral hete-
rochromatin to the nuclear lamina (Towbin et al. , 2012) (Bian et al. , 2013)
(Harr et al. , 2015). Secondly, the distributions of H3K9me2 and H3K27me3
have also been shown to be mechanosensitive, responding to forces acting on
the nucleus (Le et al. , 2016).
We found that H3K9me2 was always enriched at the nuclear periphery
regardless of cell state - Figures 5.13, 5.14, 5.16 and 5.17. Interestingly,
we observed that H3K9me2 is strongly enriched at the periphery of nuclei
that are on the outside of compact colonies of cells cultured in 2i/LIF, but
away from cell-cell junctions - Figure 5.13A/C. Upon removal of 2i/LIF,
however, after 24 hours H2K9me2 was much more uniformly distributed in
a ring - Figure 5.13B/D. It is possible that this change in distribution at
the nuclear periphery is an artefact of the staining protocol but, while hard
to rule out completely, it is unlikely as the antibody against LMNA has
no trouble penetrating to the nuclear periphery of cells inside the colony -
Figure 5.13A/B. Important to note is that this observation is independent
of LMNA expression - doxycycline LMNA   OE ES cells stained for LMNA
were shown in Figure 5.13 to demonstrate antibody penetration.
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Figure 5.13: H3K9me2 localises to nuclear periphery away from
cell-cell junctions. Immunofluorescence of H3K9me2 (green) and LMNA
(red) in LMNA   OE mouse ES cells cultured in 2i/LIF (A) and N2B27 for
24 hours (B). The distribution of H3K9me2 is shown more clearly in a heat
map in (C) and (D): in compact colonies H3K9me2 is distributed towards the
nuclear periphery of cells away from cell-cell contacts (C) - in more spread
colonies (D) the H3K9me2 is distributed in a uniform ring. N = 3.
To determine if the release from the pluripotent state (2i/LIF with-
drawal) was responsible for reorganising the distribution of H2K9me2, or
whether the e↵ect was a result of cell-matrix adhesion and spreading, we
plated LMNA   OE mouse ES cells in 2i/LIF on ibidi dishes coated in
gelatin or 10 µg/ml laminin. The former results in compact colonies that
favour cell-cell adhesion while the latter gives spread colonies that favour
matrix attachment. The results, shown in Figure 5.14, suggest that it is
cell spreading and matrix adhesion which is responsible for redistributing
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H3K9me2 from a partial ring that is enriched away from cell-cell junctions,
to a more uniform ring.
Figure 5.14: The distribution of H3K9me2 is a function of cell
spreading. Immunofluorescence of H3K9me2 in LMNA   OE mouse ES
cells cultured in 2i/LIF on gelatin (A) and 10 µg/ml laminin (B). Culturing
on gelatin results in compact colonies with cells favouring cell-cell contacts
with H3K9me2 distributed to the nuclear periphery away from cell-cell junc-
tions. Culturing on laminin results in spread colonies with a more uniform
distribution of H3K9me2 in at the nuclear periphery. N = 1.
Next, we explored what e↵ects the overexpression of LMNA and LBR
had on distributions of H3K9me2 and H3K27me3 at the nuclear envelope
during the di↵erentiation process. Figures 5.16 and 5.17 show, respectively,
representative immunofluorescence images of LMNA   and LBR ✏ ES cells
co-stained for H3K9me2 and H3K9me3 after 24 and 48 hours in N2B27.
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Quantification of the enrichment of H3K9me2 and H3K27me3 at the nu-
clear periphery was calculated using CellProfiler. To begin with, all image
channels were aligned and nuclei identified (IdentifyPrimaryObjects mod-
ule), the mask of which was used as a template to obtain more accurate
masks of H3K9me2, H3K27me3 and LMNA/LBR in their respective chan-
nels (IdentifySecondaryObjects module). Obtaining accurate masks of the
edge of the nucleus was found to be critical to ensure that the distribu-
tions calculated below were comparable. To obtain the radial distributions
of H3K9me2 and H3K27me3 we used the MeasureObjectRadialDistribution
module, its function described as follows: nuclei were first segmented into
five bands (scaling with nuclear size) at radius r, emanating from the cen-
troid of each nucleus. The radial intensity in each band was then normalised
by the total cell intensity (IT ) and then by area (A) as follows:
NIr =
Ir
IT
⇤ AT
Ar
(5.4)
An example of the results from calculating the radial distribution of
H3K9me2 in LMNA   OE ES cells after 24 hours in N2B27 (without doxy-
cycline) is shown below in Figure 5.15A, with the 5th bin showing the rel-
ative enrichment at the nuclear periphery. We also calculated the intensity
of LMNA at the nuclear periphery and, plotting a histogram of control vs.
doxycycline treated cells, identified a cut-o↵ value of LMNA intensity to ex-
clude doxycycline treated LMNA   OE ES cells that did not express LMNA
above control values from the downstream analysis. This cut-o↵ value was
chosen by eye.
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Figure 5.15: Analysing the radial distribution of histone modifi-
cations. (A) Example of output from CellProfiler analysis of the radial
distribution of H3K9me2 in LMNA   ES cells (without doxycycline) after
24 hours in N2B27. Radial distribution divided into 5 bins, with the 1st
bin representing the nuclear interior and the 5th bin the nuclear periphery.
Analysis shows strong enrichment of H3K9me2 at the nuclear periphery - as
expected from representative images (Figures 5.13, 5.14, 5.16 and 5.17). (B)
Histogram of LMNA intensity at nuclear periphery from CellProfiler anal-
ysis - used to determine a cut-o↵ value, bye eye, for LMNA   +Dox cells
(example shows 24 hours in N2B27) that do not express levels of LMNA
above control values for exclusion from downstream analysis.
The results of our analysis of the distributions of H3K9me2 and H3K27me3
with LMNA and LBR overexpression at 24 and 48 hours after 2i/LIF with-
drawal are shown below in Figure 5.18. Overexpression of LMNA and LBR
both result in a significant reduction in the relative fraction of H3K9me2 at
the nuclear periphery, as does increasing time after 2i/LIF withdrawal. The
distribution of H3K27me3 shows the opposite trend: LMNA overexpression
results in an increase in the fraction at the nuclear periphery, as does in-
creasing time after 2i/LIF withdrawal. LBR overexpression has no e↵ect on
the distribution of H3K27me3 at the nuclear periphery, however increasing
time after 2i/LIF withdrawal also lead to an increase in the relative fraction.
We have also quantified the mean whole-cell immunofluorescence stain-
ing intensities of H3K9me2 and H3K27me3, given as a percentage value
normalised to the intensity of the 24 hour N2B27 control population in Fig-
ures 5.16 and 5.17. The results show that the mean H3K9me2 intensity
increases during di↵erentiation, while the mean H3K27me3 intensity falls.
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Figure 5.16: Representative images for radial distribution analy-
sis of H3K9me3 and H3K27me3 with LMNA overexpression. Im-
munofluorescence co-stain for H3K9me2 and H3K27me3 in LMNA   mES
cells, cultured for 24 and 48 hours in N2B27 on laminin coated ibidi dishes
(10 µg/ml), +/  Dox. H3K27me3 antibody was directly conjugated to
Alexa 488 and was applied after the normal secondary antibody step. Per-
centages given in H3K9me2 and H3K27me3 images represent mean total
cell intensities - normalised to 24hr N2B27 control value. Standard error of
the mean is < 5 percent. Images show; the enrichment of H3K27me3 with
LMNA overexpression (24hr N2B27), reduction in mean total cell intensity
of H3K27me3 with di↵erentiation and an increase in mean total cell intensity
of H3K9me2 with di↵erentiation.
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Figure 5.17: Representative images for radial distribution analysis
of H3K9me3 and H3K27me3 with LBR overexpression. Immunoflu-
oresence co-stain for H3K9me2 and H3K27me3 in LBR ✏ mES cells, cultured
for 24 and 48 hours in N2B27 on laminin coated ibidi dishes (10 µg/ml),
+/  Dox. H3K27me3 antibody was directly conjugated to Alexa 488 and
was applied after the normal secondary antibody step. Percentages given
in H3K9me2 and H3K27me3 images represent mean total cell intensities -
normalised to 24hr N2B27 control value. Standard error of the mean is < 5
percent. Images show a reduction in mean total cell intensity of H3K27me3
with di↵erentiation and an increase in mean total cell intensity of H3K9me2
with di↵erentiation.
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Figure 5.18: LMNA and LBR overexpression reduce the relative
fraction of H3K9me2 at the nuclear periphery. LMNA overexpres-
sion also enriches the relative fraction of peripheral H3K27me3.
(A)/(C) Comparison of (the mean of) the mean fraction of H3K9me2 and
H3K27me3, respectively, in LMNA   mES cells cultured in N2B27 for 24
and 48 hours. (B)/(D) Comparison of (the mean of) the mean fraction
of H3K9me2 and H3K27me3, respectively, in LBR ✏ mES cells cultured in
N2B27 for 24 and 48 hours. Independent of LBR and LMNA overexpression,
increasing di↵erentiation time (24 hours to 48 hours in N2B27) significantly
reduces the relative proportion of H3K9me2 at the nuclear periphery and
enriches the relative peripheral fraction of H3K27me3. Statistics performed
using an N-Way ANOVA with the following groups - 24 hours vs. 48 hours,
Control vs. Dox and Experiment 1 vs. Experiment 2. Three asterisks rep-
resent p value < 0.001. There is a significant di↵erence between the two
experiments, however the trends in both experiments are the same.
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5.7 Discussion
This Chapter has introduced and characterised perturbations to the cy-
toskeleton and the nuclear envelope. Our goals were twofold: to reduce
the forces acting at the nuclear envelope and transmitted to chromatin and
to alter the binding between peripheral heterochromatin and the nuclear
lamina. In order to reduce forces transmitted to chromatin we: targeted
force generation in the cytoskeleton through small molecule inhibition of the
molecular motor non-muscle myosin II, overexpressed LMNA to sti↵en the
nuclear envelope and decoupled the nuclear envelope from the cytoskeleton
by breaking the LINC complex (data discussed and presented in Chapter
6). To alter the binding of peripheral heterochromatin to the nuclear lam-
ina we overexpressed and knocked-down LBR, and overexpressed LMNA,
both of which are known to be important tethering chromatin to the nuclear
envelope (Solovei et al. , 2013).
Targeting of force generation in the cytoskeleton was achieved using
the small molecule inhibitor Blebbistatin which significantly reduces nuclear
shape change - Figure 4.3. We chose to measure nuclear morphology as a
means of quantifying the e↵ect of forces acting on both bulk chromatin and,
we hoped, local fluctuations at the nuclear envelope. We found that short
term treatment (< 1 hour) with high concentrations of Blebbistatin (20 µM)
had a rapid e↵ect on cell morphology, causing compact ES colonies (2i/LIF)
to be rapidly broken apart - Figure 5.3. This observations is in agreement
with studies that have identified the importance of non-muscle myosin II
activity for the formation and stabilisation of cell-cell junctions (Shewan,
2005)(Smutny et al. , 2010). Additionally, the nuclei also became rounder,
indicative of a reduction in the magnitude of the forces acting on the nucleus.
It is possible the forces that drive nuclear elongation at the edge of ES cell
colonies are compressional from the direct contact of the nucleus with the
cell boundary. This mechanism has been proposed as an explanation for the
observation of increasing nuclear elongation with greater cell spreading in a
recent study conducted on NIH3T3 fibroblasts (Li et al. , 2015). Treatment
with high concentrations of Blebbistatin is not suitable for long term cell
culture as it blocks cellular proliferation above 2 µM - Figure 5.7. At 2 µM,
the e↵ect of Blebbistatin is very small - we observed no significant reduc-
tions in nuclear shape changes - Figure 5.10A/D, or changes to the frequency
spectrum of nuclear boundary fluctuations - Figure 5.12A. We did find an
e↵ect on nuclear morphology with an increase in circularity and solidity -
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Figure 5.9 - indicative of a loss of tension on the nucleus.
The overexpression of LMNA was designed to sti↵en the nucleus and to
provide the nuclei with an addition mechanism of tethering chromatin to
the nuclear envelope (Swift et al. , 2013)(Solovei et al. , 2013). We found
that LMNA reduced the eccentricity of the nuclei - Figure 5.9 and reduced
nuclear shape changes - Figure 5.10C/D. These findings are consistent with
LMNA acting to sti↵en the nucleus: a sti↵er nuclear envelope would result
in increased nuclear circularity, owing to an increase in energy cost to de-
form the nuclear envelope, in addition to reducing force-mediated chromatin
deformation. We did not find any di↵erences in the Fourier analysis of fluc-
tuations in the nuclear boundary when LMNA was overexpressed - Figure
5.12B. This result is expected as the frequency of oscillation of a damped
driven oscillator is determined solely by the frequency of oscillation of the
driving force. In our system, the output is the position of the nuclear enve-
lope; the driving force is periodic and generated in the cytoskeleton; and the
nuclear envelope provides both elastic and viscous damping terms. LMNA
confers the viscous component of the nuclear envelope, in contrast to LMNB1
which governs its elasticity (Shin et al. , 2013)(Swift et al. , 2013)(Harada
et al. , 2014). Addition of LMNA into the nuclear lamina would increase
the viscous damping, which would alter the amplitude and phase of nuclear
envelope fluctuations (the latter with respect to the driving force), but not
the frequency. It is worth noting that overexpression of LMNA may be
producing competing e↵ects: high levels of LMNA have been shown to in-
crease actomyosin-generated contractility through the serum response factor
(SRF) pathway (Swift et al. , 2013), which would act to increase forces on
the nucleus. It is evident, however, that sti↵ening the nuclear envelope is
the dominant e↵ect.
The overexpression of LBR, designed to increase the tethering between
heterochromatin and the nuclear envelope, had an unexpected and very
large e↵ect on nuclear morphology and the organisation of heterochromatin
- shown in Figure 5.5. We believe that the overexpression of LBR is break-
ing down the nuclear lamina and reassembling it throughout the nucleus at
sites of heterochromatin as evidenced by both the strong overlap of LBR and
heterochromatin - Figure 5.5 - and the redistribution of LMNB1 away from
the nuclear envelope and into the nucleus - Figure 5.6. These findings are
contrary to previous studies which found overexpression of LBR resulted in
increased heterochromatin density at the nuclear periphery (Solovei et al. ,
2013)(Carvajal et al. , 2015). Breakdown of the nuclear lamina would result
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in a softer nucleus that is more susceptible to forces. This is consistent with
our observations of both nuclear morphology, where LBR overexpression
causes significant drops in circularity and solidity - Figure 5.9, and nuclear
shape changes, which are significantly increased - Figure 5.10B.
The overexpression of LMNA led to a reduction in the relative fraction of
H3K9me2, and an increase in the relative fraction of H3K27me3, at the nu-
clear periphery during di↵erentiation - Figure 5.18 A/C. A large reduction in
the amount of H3K9me2 at the nuclear periphery was observed moving from
24 hours to 48 hours in N2B27, with this e↵ect being greater than that from
LMNA overexpression. The distribution of H3K27me3 showed the opposite
trend; while moving from 24 hours to 48 hours in N2B27 gave a statistically
significant increase in the amount of H3K27me3 at the nuclear periphery,
the relative increase observed from LMNA overexpression was much greater.
The overexpression of LBR also resulted in a significant drop in the relative
enrichment of H3K9me2 at the nuclear periphery, but had no e↵ect on the
distribution of H3K27me3 - Figure 5.18 B/D. We also found identical trends
in the distribution of H3K9me2 and H3K27me3 with di↵erentiation time
- moving from 24 hours to 48 hours in N2B27 resulted in a large drop in
the relative amount of H3K9me2 at the nuclear periphery, while H3K27me3
showed increased enrichment. In addition, using the average staining inten-
sities of H3K9me2 and H3K27me3 as a rough guide to the total amount in
the nucleus, we found a significant increase in H3K9me2 and a significant
reduction in H3K27me3 during di↵erentiation - Figures 5.16 and 5.17.
The large drop in the relative amount of H3K9me2 at the nuclear periph-
ery during di↵erentiation is likely due to the deposition of new H3K9me2
marks within the nuclear interior. The increase in the relative fraction of
H3K27me3 at the nuclear periphery during di↵erentiation, coupled with a
global reduction in staining intensity, implies that DNA enriched in H3K27me3
in proximity with the nuclear envelope may be preferentially protected from
enzymatic modification. This may be important for ensuring genome sta-
bility as H3K27me3 is known to repress transposons, especially during the
loss of DNA methylation which occurs during embryogenesis (Walter et al.
, 2016). The increase in the relative amount of H3K27me3 at the nuclear
periphery with LMNA overexpression is consistent with the role of LMNA
and H3K27me3 in positioning DNA at the nuclear envelope (Harr et al.
, 2015). The reduction in the relative peripheral enrichment of H3K9me2
with LMNA is, however, surprising as positioning of DNA proximal to the
nuclear lamina has also shown to be dependent on H3K9me2/3 (Towbin
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et al. , 2012)(Bian et al. , 2013)(Harr et al. , 2015). A possibility is that
H3K9me2 and H3K27me3 possess redundant functions in their interactions
with the nuclear lamina and increasing the amount of H3K27me3 at the
envelope reduces the amount of H3K9me2 - the authors in Le et al. (2016)
noted that a mechanically driven reduction in H3K9me2 at the nuclear pe-
riphery was compensated for by an upregulation in H3K27me3. Finally, we
also observed that H3K9me2 is enriched at the nuclear lamina away from
cell-cell contacts in tight colonies which shifts to a more uniform enrichment
upon cell spreading - Figure 5.14. H3K9me2 has been shown to respond to
mechanical forces in epidermal stem cells (Le et al. , 2016) and our results
suggest that H3K9me2 may also be mechanically regulated in embryonic
stem cells.
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Chapter 6
Nuclear envelope structure
influences lineage
specification, but not the exit
from naive pluripotency
This Chapter explores the e↵ect of the perturbations, introduced in Chap-
ter 5, that modify the strength of forces transmitted to chromatin and the
strength of binding chromatin binding to the nuclear lamina on the capacity
of mouse ES cells to both exit the naive pluripotent state, and to specify to
the neural lineage.
6.1 Exit from naive pluripotency
To begin with, we asked whether reducing the forces transmitted to chro-
matin by overexpressing LMNA, or perturbing the interactions between chro-
matin and the nuclear lamina by overexpressing LMNA or LBR restricted
the exit from naive pluripotency. To accomplish this, we performed a func-
tional test. Chemical restriction of ES cells to the naive pluripotent state
by culturing with 2i/LIF does not support any ES cells that have commit-
ted to di↵erentiation. By di↵erentiating ES cells towards the neural lineage
for 48 and 72 hours in N2B27 and then replating each time point at clonal
density back into 2i/LIF, any colonies that formed originated from a sin-
gle cell that had not yet entered the formative phase - we can use this to
compare the kinetics of exit from the naive pluripotent state. The results
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of the di↵erentiation rescue experiment for LBR and LMNA overexpression
are depicted below in Figure 6.1, which show that overexpression of LBR
(A) or LMNA (B) does not have an e↵ect on the kinetics of the exit from
the naive pluripotent state.
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Figure 6.1: LMNA and LBR overexpression do not alter the ki-
netics of exit from the naive pluripotent state. LMNA   and LBR ✏
ES cells cultured in 2i/LIF and N2B27 for 48 and 72 hours and replated into
2i/LIF at clonal density (400 cells total). There is no significant di↵erence
in the number of cells capable of proliferating in 2i/LIF after culturing in
N2B27 for 48 or 72 hours. Error bars display standard deviation. N = 2.
In order to solidify this result, we conducted qPCR analysis of the
pluripotency factors Nanog and Oct4 during neural di↵erentiation - shown
below in Figure 6.2 - with LBR overexpression (B), LMNA overexpression
(A) and treatment with 2 µM Blebbistatin (C), none of which show signifi-
cant di↵erences. Figure 6.2 also shows the rise and fall of an intermediate,
transition phase, transcription factor Pou3f1 and the upregulation of the
neuroectoderm marker Sox1. While we did not see any striking di↵erences
in the qPCR results, there is a lower amount of Sox1 expressed at Day 4
in N2B27 in LMNA-overexpressing mouse ES cells and a lower amount of
Pou3f1 in LBR-overexpressing ES cells after 48 hours in N2B27.
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Figure 6.2: qPCR timecourse of neural di↵erentiation in ES cells
overexpressing LBR, LMNA and treated with 2 µM Blebbistatin.
Caption on following page.
81
Figure 6.2: qPCR timecourse of neural di↵erentiation in: (A)/(D) LBR ✏
overexpressing, (B)/(D) LMNA   overexpressing and (C) E14 Tg2a + 2 µM
Blebbistatin mouse ES cells, released from 2i/LIF and cultured in N2B27 for
four days. Solid colours represent controls. Striped colours represent overex-
pression or Blebbistatin treatment. The coloured triangles represent: green
- loss of naive pluripotency (downregulation of Nanog/Oct4), blue - a transi-
tion state (upregulation and downregulation of Pou3f1), red - neural lineage
specification (upregulation of Sox1). (D) shows the levels of overexpression
of LBR and LMNA throughout the timecourse. The results show the pertur-
bations have no e↵ect on downregulation of pluripotency factors, but show
a reduction in the levels of Sox1 with LMNA overexpression - indicative of
a possible defect in neural lineage specification. Error bars display standard
deviation. N = 2.
6.2 Neural lineage specification capacity
The qPCR results above hint that the overexpression of LBR and LMNA
may be altering the kinetics or ability of mouse ES cells to commit to the
neural lineage. However, it is not possible to say more because the ex-
pression levels in the qPCR experiment are population averages. In order
to examine the distribution of Sox1 expression within the population, we
conducted immunofluorescence stains of Sox1. The staining intensity pro-
vided a quantitative measure of the amount of Sox1 protein on an individual
cell-by-cell basis. The details of the experimental setup are presented in
Chapter 2. Where appropriate, we also stained for LBR and LMNA which
allowed us to correlate the intensity levels of the LBR and LMNA pertur-
bations with Sox1, the data which is presented and discussed later below.
Histograms of the intensity of Sox1 - normalised by area - after two, three
and four days in N2B27 in mouse ES cells, are shown below in Figure 6.3
with: LBR overexpression (A), LMNA overexpression (B) and treatment
with 2 µM Blebbistatin (C). The results show that overexpression of LBR
(A) and LMNA (B) exhibit similar phenotypes: both create a bimodal re-
sponse where a significant fraction of the population does not express Sox1
after four days in N2B27 (+Dox) while the cells that have not been induced
(control) express Sox1 and are either entirely (A), or almost entirely (B)
specified to the neural lineage. Treatment with 2 µM Blebbistatin (C) re-
sults in a delay in Sox1 upregulation that e↵ects the whole population. We
then asked whether knockdown of LBR or the double knockdown of inner
nuclear envelope proteins SUN1 and SUN2 by transient transfection with
82
siRNA had a phenotype in Sox1 expression, with siRNA introduced at the
same time the 2i/LIF inhibitors were withdrawn. SUN1 and SUN2 form
part of the LINC complex, binding the KASH domain of the nesprins in the
space between the inner and outer nuclear membranes, with Sun1 expressed
tenfold higher than Sun2 in ES cells (RNA-Seq data - not shown). The re-
sults of the LBR and SUN1/2 double knockdown on intensity of Sox1 after
culturing in N2B27 for 48 and 72 hours are shown in Figure 6.4A, neither
of which show a phenotype. Knockdown of LBR was verified at the pro-
tein level by immunostaining - Figure 6.4C/D, and at the transcript level by
qPCR - Figure 6.4E. The results show that LBR was successfully knocked
down at the protein level 48 hours after transfection with 10% of the tran-
script remaining; however, after 72 hours in N2B27 the protein had returned
to control levels and the transcript to 30% of control. Unfortunately, while
we were able to obtain a reliable antibody for SUN2, we could not find an
antibody for SUN1 which meant that we were unable to verify knockdown of
SUN1 at the protein level. The e↵ectiveness of SUN1/2 double knockdown
was therefore assessed at the transcript level with qPCR - Figure 6.4E -
which showed that Sun1 was reduced to 35% of control levels after 48 hours
and had returned to 70% of control by 72 hours. Sun2 was knocked down
to 20% of control levels after 48 hours and had risen to 40% of control 24
hours later. It is therefore unlikely, comparing expression levels of Sun1 with
those of Lbr, that knockdown at the protein level was likely to have been
successful.
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Figure 6.3: LMNA and LBR overexpression blocks neural lineage
specification in a bimodal fashion - treatment with 2 µM Blebbis-
tatin delays it. Sox1 immunofluorescence in (A) LBR ✏ overexpressing, (B)
LMNA   overexpressing and (C) E14 Tg2a + 2 µM Blebbistatin mouse ES
cells di↵erentiated towards neuroectoderm. Histograms for Sox1 intensity
are shown at Day 2, Day 3 and Day 4 after 2i/LIF withdrawal, normalised
so their total area is one. N = 3.
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Figure 6.4: Knockdown of LBR has no e↵ect on the kinetics of neu-
ral lineage specification. (A)/(B) Immunofluorescence of Sox1 after 48
and 72 hours in N2B27, respectively, in E14 Tg2a mouse ES cells treated with
scrambled siRNA, Sun1&2 siRNA and Lbr siRNA. Results show no signifi-
cant di↵erences in the intensity distributions of Sox1. (C)/(D) Knockdown
of LBR verified by immunofluorescence - LBR intensity was successfully re-
duced on day 2 but returned to control levels by day 3. (E) Knockdown
of LBR and SUN1&2 assessed by qPCR. Error bars represent the standard
error of the mean. Sun1 expression levels, with siRNA treatment, do not
indicate that knockdown was likely to have been successful. N = 2.
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6.3 Correlating the intensity of Sox1 with LMNA
and LBR overexpression
The next step was to determine whether there were any correlations be-
tween the levels of overexpression of LMNA and LBR and the amount of
Sox1, as determined by immunofluorescence. Figure 6.5 shows the scatter
plot of LMNA intensity vs. Sox1 intensity (A) and of LBR intensity vs.
Sox1 intensity (B) after 72 hours in N2B27, using the data from Figure 6.3A
and 6.3B. The results show a strong negative correlation between the inten-
sity of LMNA and Sox1: the vast majority of LMNA-overexpressing cells
do not express Sox1 at all. The correlation between the intensity of LBR
and Sox1 is more complicated: the control population of non-induced LBR-
overexpressing ES cells is positively correlated with the intensity of LBR
which means that more analysis is necessary to determine what the e↵ect
LBR overexpression is having on the intensity of Sox1.
Figure 6.5: Intensity correlations between LMNA/LBR and Sox1
in LMNA  /LBR ✏ overexpressing mouse ES cells. (A) Scatter plot
of Sox1 intensity vs. LMNA intensity by immunofluorescence in LMNA  
overexpressing mouse ES cells cultured in N2B27 for 72 hours. (B) Scatter
plot of Sox1 intensity vs. LBR intensity by immunofluorescence in LBR ✏
overexpressing mouse ES cells cultured in N2B27 for 72 hours. The intensity
of LMNA shows a strong negative correlation with the intensity of Sox1. The
intensity of endogenous LBR (control) shows a positive correlation with Sox1
intensity which complicates e↵ect of LBR overexpression and necessitates a
more detailed analysis.
In order to investigate the correlation between Sox1 and LBR, we first
divided up the populations of doxycycline treated and control LBR over-
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expressing mouse ES cells into quartiles based on their intensity of LBR -
Figure 6.6A. As expected, because the overexpression of LBR is not uni-
form when induced, the bottom quartile of LBR overexpressing cells have
the same intensity of LBR when comparing control vs. doxycycline treated
whereas, in the upper quartile, the doxycycline treated cells have signifi-
cantly higher intensities of LBR when compared with controls. We noticed
that the density of cells changed throughout the dish - Figure 6.6B - and
that the density of cells was greater in regions that expressed high levels of
LBR - Figure 6.6C. We then took the cells in the upper and lower quartiles
of LBR intensity and separated them again into quartiles of high and low
density, before making boxplots of their Sox1 intensity - Figure 6.6D. The
results show that, in both high and low density regions in cells expressing
high levels of LBR the cells treated with doxycycline express significantly
lower levels of Sox1 when compared with controls. In spite of the positive
correlation between Sox1 and LBR intensity, shown in Figure 6.5B, when the
e↵ects of density are taken into account overexpression of LBR negatively
correlates with Sox1.
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Figure 6.6: LBR intensity negatively correlates with Sox1 inten-
sity. Caption on following page.
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Figure 6.6: Immunofluorescence of Sox1 and LBR in LBR ✏ overexpressing
mouse ES cells, cultured in N2B27 for 72 hours. (A) Boxplots of upper
and lower quartiles of LBR intensity. Doxycycline treatment gives a wide
range of LBR intensities - high LBR levels are significantly higher with Dox
treatment when compared with controls. (B) DNA stain (Hoechst 33342)
showing changes in cell density. (C) Boxplots of upper and lower quartiles
of cell density/proportion of cell in contact with neighbours, gated on LBR
intensity using data in (A). (D) Normalised Sox1 intensity - gated on LBR
intensity and cell density - data from (C). LBR negatively correlates with
Sox1 intensity when the data is gated on both LBR expression and density
e↵ects are taken into e↵ect - in the high LBR intensity quartile, irrespective
of density, Sox1 expression is lower in Dox treated cells. Statistical analysis
performed in MATLAB using a Kruskal-Wallis test, followed by a multi-
comparison test. Boxplots with separate letters indicate that theirs means
are significantly di↵erent at the 5% level.
6.4 Discussion
This Chapter has explored the e↵ect of both reducing forces transmitted
to chromatin, through inhibition of non-muscle myosin II and sti↵ening of
the nuclear envelope with LMNA, and altering the binding of peripheral
heterochromatin to the nuclear lamina, through overexpression of LMNA
and LBR, on the ability of embryonic stem cells to exit the naive pluripotent
state and specify to the neural lineage. Our hypothesis is that forces acting
at the nuclear envelope are required to facilitate access to lineage specific
genes that are sequestered there in the pluripotent state and required during
the di↵erentiation process - where global changes in transcription occur. We
have shown that the overexpression of LMNA or LBR does not a↵ect the
ability of ES cells to exit the naive pluripotent state - Figure 6.1. These
results indicate that, while the nuclear envelope may play an active role in
the silencing of nearby genes (Finlan et al. , 2008) (Reddy et al. , 2008)
(Zullo et al. , 2012), close proximity to the nuclear lamina is unlikely to be
a requirement for transcriptional repression.
The next step was to look at the e↵ect our perturbations have on the
ability of mouse ES cells to di↵erentiate towards the neural lineage, the evi-
dence of which is given by the expression of the neuroectoderm marker Sox1.
While we did not find significant changes in Sox1 expression with LBR over-
expression and 2 µM Blebbistatin treatment, we found a downregulation of
Sox1 at Day 4 after 2i/LIF withdrawal with LMNA overexpression - Figure
6.2. Inhibition of non-muscle myosin II in both human and mouse embry-
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onic stem cells has been shown to enhance the self-renewal factors Nanog
and Oct4 (Walker et al. , 2010). We did not see this e↵ect in the qPCR
data, however, it is important to note we were using a much lower dose of
Blebbistatin at 2 µM, compared with the 10 µM required in the previous
study to see significant enhancements in Nanog and Oct4 expression.
To look at the distribution of Sox1 expression within the population we
stained for Sox1 using immunofluorescence. We found that LBR and LMNA
overexpression created a bimodal distribution of Sox1 where a significant
fraction of the population did not express Sox1 at all, while treatment with
2 µM Blebbistatin delayed Sox1 expression in the whole population - Figure
6.3A, 6.3B and 6.3C, respectively. When looking at the correlations between
LMNA intensity and the intensity of Sox1 it is clear that overexpression of
LMNA above a threshold blocks Sox1 expression - Figure 6.5A. We did
not find any significant di↵erences in the rate of proliferation upon LMNA
overexpression - Figure 5.7C, which indicates that the LMNA phenotype is
likely a result of either decreasing forces propagated to chromatin through
the nuclear envelope, or altering the interactions of chromatin with nuclear
lamina - or a combination of the two. If the block on Sox1 expression upon
overexpression of LMNA was a result of reducing the forces transmitted to
chromatin, we would expect that reducing the forces on the nucleus by other
means, such as targeting force generation in the cytoskeleton with Blebbis-
tatin, would have a similar phenotype. In order to avoid blocking cell division
we had to use a low concentration of Blebbistatin (2 µM) - Figure 5.7A - such
that the forces on the nucleus were not significantly reduced - Figure 5.10A
and 5.10B. However, in spite of this, we found a delay in Sox1 expression -
Figure 6.3C - which implies that neural di↵erentiation may be very sensitive
to forces. It is interesting to note that, in more specialised stem cells - for
example muscle stem cells (myoblasts) - LMNA expression is required for
di↵erentiation, with LMNA null or mutant mice displaying impaired di↵er-
entiation kinetics and loss of potential (Frock et al. , 2006)(Perepelina et al.
, 2017). A possible explanation for this may lie in the increasing importance
of LMNA as a regulator of chromatin interactions at the nuclear periphery
in more di↵erentiated cell types (Solovei et al. , 2013) and the requirement
for LMNA in cell types that undergo high mechanical strains (Swift et al. ,
2013).
The overexpression of LBR was designed to strengthen the binding be-
tween LADs and the nuclear lamina, without modulating the forces trans-
mitted to chromatin. We found, however, that LBR overexpression had
90
a rather drastic e↵ect on nuclear morphology and the architecture of the
nuclear envelope by, we believe, disassembling the nuclear lamina and re-
assembling it at sites of heterochromatin throughout the nucleus - Figures
5.5 and 5.6. A parallel may be drawn with the shape of granulocyte (neu-
trophil) nuclei which, albeit to a more extreme extent, are multi-lobed: a
characteristic thought to aid them in squeezing through small spaces gaps as
part of their function. It is known that su cient levels of LBR are required
for realising this shape (Ho↵mann et al. , 2007)(Olins et al. , 2008) and it
is possible that the overexpression LBR in our ES cell system is driving a
similar process.
Given such drastic alterations in nuclear organisation upon LBR overex-
pression it is challenging to interpret the results of the bimodal distribution
of Sox1 in the context of our hypothesis - forces on the nucleus are no longer
required to move chromatin in proximity to the nuclear envelope to interact
with the lamina because the nuclear lamina moves to the chromatin. It is
therefore not possible to compare the phenotype in Sox1 from LBR overex-
pression to that of LMNA overexpression. We have shown, however, that
when separated from e↵ects due to cell density - Figure 6.6 - LBR overex-
pression negatively correlates with Sox1. The positive correlation of Sox1
and LBR can be explained as a density e↵ect - if the amount of Sox1 or LBR
remains constant in the nucleus, the mean intensity (measured) will rise as
the projected nuclear area falls.
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Chapter 7
General discussion and
future directions
This final Chapter will first discuss current work: in particular, our prelim-
inary results from decoupling the nucleus from the cytoskeleton with the
overexpression of truncated nesprins that were introduced at the beginning
of Chapter 5 in Figure 5.1. Our findings so far will then be summarised and
discussed, and the directions in which this project might be taken presented.
7.1 Decoupling the nucleus from the cytoskeleton
The final set of perturbations are the overexpressions of truncated nesprins,
depicted in Figure 5.1, designed to break the physical link between the
cytoskeleton and the nucleus by out-competing endogenous nesprins for
SUN1/2 protein binding at the inner nuclear membrane. Due to time con-
straints, these perturbations are not fully characterised and all experiments
so far have been conducted using polyclonal lines. Figure 7.1, below, shows
that the mRFP-SR-KASH proteins localise, as expected, to the nuclear en-
velope. There is a large dynamic range in the amount of protein expression:
cells expressing high levels appear to be saturated at the nuclear envelope
and the protein distributed throughout the cytoplasm while cells that ex-
press low levels show faint rings outlining the nucleus, or no signal at all.
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Figure 7.1: mRFP-SR-KASH localises to the nuclear envelope
when overexpressed. Polyclonal mRFP-SR-KASH mouse ES cell line
were cultured in 2i/LIF in ibidi dishes and doxycycline treated for 24 hours.
The truncated spectrin repeat KASH domain containing proteins, fused to
mRFP, localise to the nuclear envelope as expected. In cells containing high
levels of the protein the nuclear envelope is saturated and the protein is dis-
tributed throughout the cytoplasm. In lower levels of expression, the protein
is completely localised at the nuclear envelope.
7.2 Neural lineage capacity - preliminary results
In order to see whether reducing the forces transmitted to chromatin by
breaking the LINC complex had an impact on ES cell di↵erentiation to-
wards the neural lineage we conducted immunofluorescent stains for Sox1
at days two, three and four after 2i/LIF withdrawal, the results of which
are shown below in Figure 7.2. The details of the experimental setup and
analysis can be found in Chapter 2. The results show that overexpression
of mRFP-SR-KASH and mRFP-KASH, both of which act as dominant neg-
atives for the endogenous nesprins, blocks the expression of Sox1 in the
majority of cells after 3 days in N2B27 - Figure 7.2A and 7.2B, respectively.
The overexpression of mRFP-KASH L, which acts as a control for the over-
expressions of mRFP-SR-KASH and mRFP-KASH, also exhibits a bimodal
response in Sox1 expression, however, the e↵ect is much weaker and the
majority of the cells express Sox1. The correlations of Sox1 intensity with
mRFP-SR-KASH, mRFP-KASH and mRFP-KASH L are shown in Figure
7.3. The results show that, in cells that are expressing Sox1, overexpres-
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sion of mRFP-SR-KASH and mRFP-KASH negatively correlates with Sox1
while overexpression of mRFP-KASH L shows no correlation. Of the cells
that do not express Sox1, however, there is no correlation in the intensities
of mRFP-SR-KASH, mRFP-KASH and mRFP-KASH L.
The preliminary results of the overexpression of the KASH constructs
on the ability of mouse ES cells to di↵erentiate towards the neural lineage
are extremely encouraging. It appears that decoupling the nucleus and the
cytoskeleton by breaking the LINC complex and, we hope, reducing the
forces transmitted to chromatin is blocking neural di↵erentiation. At this
moment it is hard to say why there is proportion of cells, shown by the
correlations in Figure 7.3, that do not express Sox1 or the KASH constructs
(when induced). A possible explanation lies in the increased heterogeneity
that comes from using polyclonal lines; the way of testing which will to be
to use clonal lines in future experiments. These results, if reproducible, lend
strength to the requirement of forces acting at the nuclear envelope in the
process of mouse ES cell di↵erentiation.
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Figure 7.2: Decoupling of the LINC complex through expression
of N-terminal truncated nesprins delays di↵erentiation towards
neuroectoderm in a bimodal fashion. Sox1 immunofluorescence in
(A) mRFP-SR-KASH overexpressing (polyclonal), (B) mRFP-KASH over-
expressing (polyclonal) and (C) mRFP-KASH L mouse ES cells di↵eren-
tiated towards neuroectoderm. Histograms for Sox1 intensity are shown
at Day 2, Day 3 and Day 4 after 2i/LIF withdrawal, normalised so their
total area is one. SR-KASH and KASH act as dominant negatives and out-
compete endogenous nesprins for SUN1/2 binding. N = 1.
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Figure 7.3: Intensity correlations between KASH construct pro-
teins and Sox1 in KASH construct overexpressing cells. (A) Scatter
plot of Sox1 intensity vs. mRFP-SR-KASH intensity by immunofluorescence
in polyclonal mRFP-SR-KASH overexpressing mouse ES cells cultured in
N2B27 for 72 hours. (B) Scatter plot of Sox1 intensity vs. mRFP-KASH
intensity by immunofluorescence in polyclonal mRFP-KASH overexpressing
mouse ES cells cultured in N2B27 for 72 hours. (C) Scatter plot of Sox1 in-
tensity vs. mRFP-KASH L intensity by immunofluorescence in polyclonal
mRFP-KASH L overexpressing mouse ES cells cultured in N2B27 for 72
hours. Cells that express Sox1 negatively correlate with the intensity of
mRFP-SR-KASH and, to a lesser degree, mRFP-KASH but show no corre-
lation with the intensity of mRFP-KASH L. N = 1.
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7.3 Summary of results
Chapter 3 explored the mobility of H2B-eGFP in mES cells in the naive
pluripotent state and during di↵erentiation, using FRAP. We found that:
• The nuclei of mES cells undergo large, dynamic changes in shape -
capable of moving chromatin on a bulk scale.
• There is a significant increase in the mobility of H2B-eGFP that is
loosely bound to chromatin two hours after 2i/LIF withdrawal.
Chapter 4 investigated the role of the cytoskeleton in generating and
propagating forces to the nucleus, using nuclear shape changes as a proxy.
By developing two complementary methods of quantifying nuclear shape
changes we have shown that:
• Nuclear shape changes are driven by actomyosin in the cytoskeleton:
requiring both tension generated through non-muscle myosin II and
the turnover of actin.
• Nuclear shape changes are not random but have a well-defined period
of oscillation on the order of 200 seconds.
• The intensity of cortical actin also has a dominant oscillatory frequency
on the order of 200s.
• There is a correlation between cortical actin intensity and local move-
ments of the nuclear envelope: fluctuations in cortical actin intensity
oscillate with a phase of ⇡ ahead of oscillations in nuclear envelope
position.
Chapter 5 introduced the perturbations to our mouse embryonic stem cell
system. We had two goals: to reduce the forces transmitted to chromatin and
to modulate the interactions of chromatin at the nuclear periphery with the
nuclear lamina. To reduce forces actin on chromatin we used two approaches.
The first was to use the small molecule inhibitor Blebbistatin to block the
phosphorylation of non-muscle myosin II in the cytoskeleton, inhibiting its
action and, subsequently, its ability to generate forces. The second approach
was to modify the structure of the nuclear envelope to modulate force trans-
mission - the overexpressing LMNA was designed to sti↵en the nucleus and
the overexpression of N-terminal truncated nesprins to decouple the nucleus
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and the cytoskeleton by breaking the LINC complex (discussed later). We
also attempted to break the LINC complex at the inner nuclear membrane,
by knocking down the SUN proteins. To alter the binding between periph-
eral chromatin and the nuclear lamina, we again targeted proteins in the
nuclear envelope: the overexpressions of LMNA and LBR were designed to
increase chromatin tethering to the nuclear lamina and the knockdown of
LBR to reduce it. The results of the characterisation of our perturbations
are as follows:
• Treatment with Blebbistatin, restricted to a low concentration of 2
µM to avoid blocking cellular proliferation, did not significantly a↵ect
nuclear shape changes but did a↵ect nuclear morphology - increasing
circularity.
• Overexpression of LMNA, which localised as expected to the nuclear
envelope, reduced the e↵ect of forces on the nucleus - evidenced by a
reduction in nuclear shape changes and eccentricity.
• The overexpression of LBR had an unexpected and drastic e↵ect on nu-
clear morphology - decreasing circularity and solidity - and chromatin
organisation, by assembling nuclear lamina like structures within the
nuclear interior.
• Knockdown of LBR had the opposite e↵ect on nuclear morphology
when compared with LBR overexpression - increasing circularity, so-
lidity and reducing nuclear area.
• Treatment with 2 µM Blebbistatin or LMNA overexpression did not
a↵ect the frequency spectrum of oscillations in the nuclear boundary.
• Overexpression of LMNA reduced the relative fraction of H3K9me2
and increased the relative fraction of H3K27me3 at the nuclear enve-
lope during di↵erentiation (24 and 48 hours in N2B27).
• Overexpression of LBR reduced the relative fraction of H3K9me2 at the
nuclear periphery during di↵erentiation (24 and 48 hours in N2B27),
but had no e↵ect on the distribution of H3K27me3.
• We found evidence of possible mechanical regulation of H3K9me2 which
shifts in distribution from upon cell spreading: in compact colonies
H3K9me2 is enriched at the nuclear periphery, but not near cell-cell
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junctions. When the colonies are more loosely bound and the cells
spread, H3K9me2 forms a ring around the entire nuclear periphery.
Chapter 6 explored the e↵ect of the perturbations introduced in the pre-
vious Chapter on the exit from the naive pluripotent state and di↵erentiation
towards the neural lineage. In particular, we were interested in looking for
changes in di↵erentiation kinetics or capacity. To begin with we looked at the
kinetics of exit from naive pluripotency with a function assay: by di↵erenti-
ating cells in N2B27 and then replating back into 2i/LIF and counting the
fraction of colonies recovered, we could determine what fraction of the pop-
ulation had irreversibly committed to di↵erentiation. We then used qPCR
to look at transcriptional changes that accompany the start of the di↵eren-
tiation process, at a population level, and then immunofluorescence to look
at the distribution of the neuroectoderm specification marker Sox1 in more
detail. The results are summarised below:
• Overexpression of LMNA or treatment with 2 µM Blebbistatin did not
alter the kinetics of exit from the pluripotent state.
• Overexpression of LBR and LMNA created a bimodal distribution in
Sox1, in which a significant fraction of the population does not express
the neuroectoderm specification marker.
• Treatment with 2 µM Blebbistatin delayed upregulation of Sox1 in all
cells.
• Knockdown of LBR had no e↵ect on the distribution of Sox1, nor did
knockdown of Sun1/2. It is likely, unfortunately, that the knockdown
of Sun1 was not successful.
• Overexpression of LMNA negatively correlates with expression of Sox1,
as does the overexpression of LBR when separated from density e↵ects.
Lastly, this Chapter has presented preliminary results which show that
decoupling the nucleus from the cytoskeleton through overexpression of N-
terminal truncated nesprins blocks Sox1 expression in a bimodal fashion.
Correlations of the KASH constructs with Sox1 expression show that, in
cells expressing Sox1 - there is a negative correlation with the intensities
of mRFP-SR-KASH and mRFP-KASH, but no correlation with the control
mRFP-KASH L. This strongly indicates that the decoupling of the LINC
complex is responsible for blocking neural specification.
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7.4 General discussion
The goal of this research was to investigate the role of forces acting at the
nuclear envelope in the context of mouse embryonic stem cell di↵erentiation,
specifically, whether they are important for exit from the naive pluripotent
state and lineage specification. Our hypothesis was that forces are required
to facilitate access to lineage specific genes, repressed and bound at the
nuclear lamina. By modulating the forces transmitted to chromatin, or
perturbing the interactions of chromatin at the nuclear periphery with the
nuclear lamina, we hoped to alter the kinetics, or capacity, of mouse ES cells
to di↵erentiate. To a large extent we have met these goals.
At the beginning of the project we investigated the dynamic nature of
H2B-eGFP using FRAP in the pluripotent state and during the early stages
of di↵erentiation. We sought to build upon the work done by Meshorer et al.
(2006), who had shown that major architectural proteins (e.g. histone pro-
teins) are dynamic and loosely bound to chromatin in ES cells, but become
immobilised in ES cells that are lineage committed. The authors suggested
that this ’hyperdynamic’ binding of chromatin proteins was a hallmark of
the pluripotent state and demonstrated that restricting the movement of
histone H1 resulted in arrested di↵erentiation. Using our in vitro embryonic
stem cell culture system, which - through inhibition of GSK3 (CHIRON)
and MEK activity (PD03) - has significantly less transcriptional heterogene-
ity within the population when compared with serum based culture (used in
Meshorer et al. (2006)), we were able to explore changes in H2B-eGFP mo-
bility during the early stages of di↵erentiation. H2B-eGFP showed FRAP
recovery kinetics present on two timescales, corresponding to two pools of
H2B-eGFP with separate chromatin interactions. H2B-eGFP exhibited an
initial rapid recovery, with an exponential profile and a time constant < 15
seconds, corresponding to a pool of freely di↵using H2B-eGFP. Recovery of
H2B-eGFP intensity in the bleached region then occurred in a linear fashion
with timescales > 15 seconds, corresponding to a pool of H2B-eGFP that is
loosely bound to chromatin. This behaviour mirrors the findings of Meshorer
et al. (2006).
The significant increase in the mobility of loosely bound H2B-eGFP ob-
served two hours after 2i/LIF withdrawal suggests that chromatin organisa-
tion may be changing rapidly after release from the pluripotent state. This
is consistent with rapid changes that have been shown to occur the tran-
scriptional level; naive pluripotency factor mRNA declines by 70% within
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4 hours of 2i/LIF withdrawal (Kalkan & Smith, 2014)(Leeb et al. , 2014).
While performing the FRAP experiments we noticed that mES cell nuclei
were undergoing large and dynamic changes in shape which were capable of
moving chromatin on a bulk level. We sought to characterise and investigate
the origin of these shape changes.
We have presented strong evidence for the necessity of both the poly-
merisation of actin and cytoskeletal tension, generated through non-muscle
myosin II, in creating and propagating the forces that act on the nucleus -
driving shape changes. There are a couple of possible mechanisms: The first
requires a physical connection between the nucleus and the cytoskeleton.
Pre-stress in the cytoskeleton allows forces, generated internally or applied
externally to the cell, to be propagated over large distances (Jaalouk & Lam-
merding, 2009)(Wang et al. , 2009). If we inhibit the activity of non-muscle
myosin II there is no tension to propagate forces to the nucleus, nor are
there any forces generated in the cytoplasm. In addition, if we stabilise the
polymerisation of actin then, while the cytoskeleton is capable of propagat-
ing forces, the forces on the nucleus are static. These e↵ects would lead
to a significant reduction in the amplitude of nuclear shape changes. The
second mechanism requires a fluid flow around the nucleus, generated by
actomyosin contractility. The flow of fluid would exert a dynamic pressure
on the nucleus, with the physical connections of the cytoskeleton and the
nucleus acting as local anchors, leading to shape changes. This mechanism
has been postulated to explain rotations observed in the nuclei NIH 3T3
mouse embryonic fibroblasts (Kumar et al. , 2014). A path that could be
taken to determine the relative contribution of each mechanism to driving
nuclear shape changes in ES cells is presented in the next section.
The fluctuations in the nuclear envelope possess a well-defined period
of oscillation of approximately 200 seconds. This compliments a previous
study, which found fluctuations in the projected area of mES cells with an
oscillatory period centred on 140 seconds (Talwar et al. , 2013). A novel
finding of this research, however, is the presence of oscillations in local in-
tensity of cortical actin, which possess the same period as the fluctuations in
the nuclear boundary. Taking the cross-correlation between the local inten-
sity of cortical actin and the local position of the nuclear envelope (radially
inwards) revealed a clear relationship between the two, with cortical actin
intensity fluctuating ⇡ radians out of phase with, and ahead of, the position
of the nuclear boundary. This is strong evidence that the processes driving
fluctuations in cortical actin are linked to the changes in nuclear shape. It
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is thought that there is an optimum F-actin length and crosslinking den-
sity within the mesh (a function of F-actin density) for generating myosin
II mediated contractility and subsequent force propagation (Chugh et al. ,
2017). We can speculate that this may provide an explanation for hysteresis
in the system and the phase lag of ⇡ between the movement of the nuclear
boundary and the intensity of cortical actin. If F-actin density fluctuates
about the optimum density for force generation, this would create a phase
lag of ⇡ between the local force maximum and cortical F-actin intensity.
The first set of perturbations, designed to reduce forces transmitted to
chromatin, was the overexpression of LMNA and treatment with 2 µM Bleb-
bistatin - both of which altered nuclear morphology to be more circular, in-
dicative of either a loss of tension on the nucleus or sti↵ening of the nuclear
envelope. Only the overexpression of LMNA, however, significantly reduced
nuclear shape changes, consistent with its role in sti↵ening the nucleus (Lam-
merding et al. , 2006)(Swift et al. , 2013). Neither of these perturbations
altered the kinetics of exit from naive pluripotency, which implies that as-
sociation with the nuclear lamina, while capable of actively silencing genes
(Finlan et al. , 2008)(Reddy et al. , 2008), is not required to repress the
genes that constitute the pluripotency network. We might have expected to
find a delay in the exit from naive pluripotency with Blebbistatin treatment,
which has been shown to promote self-renewal and increase the expression
of the pluripotency factors Nanog and Oct4 (Walker et al. , 2010). A likely
explanation for why we did not find this, however, is that the concentration
of Blebbistatin used in our experiments - required for viability in long-term
culture - was too low.
Overexpression of LMNA did, however, block mouse ES cells from com-
mitting to the neural linage - a significant fraction of the population did
not express Sox1 at all, with those that did expressing the lowest levels
of LMNA. Remarkably, despite not significantly reducing nuclear shape
changes, treatment with 2 µM Blebbistatin delays Sox1 expression on a
population level. The final perturbations designed to reduce forces trans-
mitted to chromatin were the overexpressions of N-terminal truncated ne-
sprins (KASH constructs), which act as dominant negatives for endogenous
nesprins and decouple the nucleus from the cytoskeleton (Luxton et al. ,
2011). Preliminary results are very promising - a significant fraction of the
(overexpressing) population did not express Sox1, with the fraction that did
negatively correlating with the level of overexpression. These results, when
taken together, provide strong evidence that the process of mES cell lin-
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eage specification may be very sensitive to, and require, forces acting at the
nuclear envelope.
The perturbations designed to modulate the interactions between pe-
ripheral heterochromatin and the nuclear lamina were the overexpression of
LMNA and the overexpression and knockdown of LBR. LMNA and LBR
are thought to be components of two separate mechanical tethers that bind
chromatin to the nuclear envelope (Solovei et al. , 2013) - association with
which is correlated, although not exclusively, with transcriptional repres-
sion (Guelen et al. , 2008)(Peric-Hupkes et al. , 2010). While LMNA was
correctly localised to the nuclear lamina, LBR - when overexpressed - was
distributed throughout the nucleus and overlapped with regions of hete-
rochromatin. Additionally, nuclear shape was significantly perturbed with
large invaginations. Interestingly, although not as extreme, the shape re-
sembles that of granulocytes - which possess a lobulated nuclei and require
an adequate amount of LBR to form (Ho↵mann et al. , 2007)(Olins et al. ,
2008). We believe that LBR, which recognises and binds to chromatin with
repressive histone modifications - notably H3K9me2 and H3K27me3 - is as-
sembling nuclear lamina-like structures at sites of heterochromatin within
the nucleus and changing their structure. Overexpression of LBR was found
to block expression of Sox1 during di↵erentiation. It is, however, challenging
to interpret this result in the context of forces acting at the nuclear envelope
in a meaningful way, because the nuclear lamina has moved to sites of hete-
rochromatin, and not the other way around. Knockdown of LBR by siRNA,
while it made nuclei more circular, did not a↵ect the capacity for, or kinetics
of, neural lineage specification.
To investigate whether overexpression of LMNA and LBR was altering
chromatin interactions at the nuclear lamina we looked at the radial distri-
butions of the repressive histone modifications H3K9me2 and H3K27me3,
required for targeting and binding of chromatin to the nuclear lamina (Harr
et al. , 2015), during di↵erentiation. LMNA overexpression depleted H3K9me2
and enriched H3K27me3 at the nuclear periphery. LBR overexpression also
depleted H3K9me2 at the nuclear periphery, but had no e↵ect on the distri-
bution of H3K27me3. Independent of the perturbations, the relative fraction
of H3K9me2 dropped significantly at the nuclear periphery during di↵eren-
tiation - from 24 hours to 48 hours in N2B27, while the relative fraction of
H3K27me3 increased. We expected to find an enrichment of both H3K9me2
and H3K27me3 at the nuclear periphery if genes were being restricted there.
It was, therefore, surprising that the relative fraction of H3K9me2 at the nu-
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clear periphery dropped with LMNA overexpression. Again, the results of
the distributions of H3K9me2 and H3K27me3 with LBR overexpression are
hard to interpret given the large e↵ect LBR overexpression has on nuclear
shape and unexpected localisation throughout the nucleus. It is possible
that the enrichment of H3K27me3 is replacing the loss of H3K9me2 in a
compensatory fashion - an e↵ect that has been observed in epithelial stem
cells (Le et al. , 2016). What remains to be reconciled with the Le et al.
(2016) study, however, is that H3K9me2 enrichment at the nuclear periphery
in epithelial stem cells was lost when the nuclei were placed under tension,
stretching them - contrary to our system in which LMNA overexpression re-
duces the forces transmitted to chromatin. It is important to note, however,
that the mechanism proposed for driving H3K9me2 depletion at the nuclear
envelope in epidermal stem cells, when stretched, was traced to structural
re-organisation of the cytoskeleton, the arrangements of which di↵er signifi-
cantly from that of ES cells (epithelial stem cells possess more F-actin stress
fibres and F-actin is not localised to the cortex). Nevertheless, our evidence
does suggest that the distributions of H3K9me2 and H3K27me3 may be
mechanosensitive in ES cells.
Finally, we observed additional evidence of possible mechanosensitivity of
H3K9me2: the repressive histone modification was enriched at the periphery
of nuclei on the edges of cells, but not when in close proximity with cell-cell
junctions, creating a partial ring. This e↵ect was lost during di↵erentiation,
where the nuclear periphery was enriched in H3K9me2 in a complete ring.
Whether this was a result of the transcriptional changes that occur during
di↵erentiation, or tied to changes in cell morphology, notably cell spreading
was unclear. As a preliminary experiment, we cultured mouse ES cells in
2i/LIF on gelatin and laminin, the former creating tight colonies and the
latter colonies that were more spread. The spread colonies had complete
rings of H3K9me2 whereas tight colonies had partial rings away from cell-cell
junctions in nuclei at the edges of colonies. This suggests that H3K9me2 may
be mechanically regulated as its distribution is tied to cellular morphology.
It is interesting to note that H3K9me2 is preferentially enriched in areas
of the nuclear periphery next to regions of the cytoskeleton that are highly
contractile, which occurs in cells at the edges of colonies in 2i/LIF (Rosowski
et al. , 2015).
To conclude, this project has characterised and uncovered novel relation-
ships between the dynamics of nuclear shape changes in mouse embryonic
stem cells and the components of the cytoskeleton responsible for creating
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and propagating forces to the nucleus. We have demonstrated that forces
acting on the nucleus are required for ES cell neural lineage specification, but
not the exit from naive pluripotency. We have also found evidence that the
repressive histone modifications H3K9me2 and H3K27me3, which modulate
the interactions of chromatin with the nuclear lamina, are mechanosensitive.
While we cannot conclude from this research that nuclear shape changes are
responsible for facilitating the movements of lineage specific genes to and
from the nuclear lamina, observed by Peric-Hupkes et al. (2010), we have
made significant progress and laid the groundwork for tackling this question.
In the next section I will discuss the next steps that could be taken.
7.5 Future directions
There are several ways in which this project can be developed. In the short
term the most pressing goal is to fully characterise the KASH constructs;
whether they are reducing nuclear shape changes, and therefore reducing
forces on the nucleus, and to ensure that the neural lineage specification
experiments are reproducible. Additionally, characterising the magnitude
of the nuclear shape changes with the KASH constructs should provide an
insight into how the forces are propagated to the nucleus. If forces are
transmitted through the cytoskeleton directly to chromatin, then breaking
the LINC complex should reduce nuclear shape changes. If, on the other
hand, forces are being exerted on the nucleus by fluid flow in the cytoplasm,
then breaking the LINC complex would likely not reduce the nuclear shape
changes.
In the long term it will be important to show that genes are being misreg-
ulated at the nuclear envelope when forces that are transmitted to chromatin
are perturbed. There are a few complementary approaches to this that could
be taken. The first is to look at the physical location of important lineage
genes (e.g. Sox1) in relation to the nuclear envelope during di↵erentiation.
The technique most suited for this is DNA fluorescence in situ hybridisation
(FISH). FISH relies on the ability to create fluorescently labelled probes
containing DNA sequences that are complementary to the DNA sequence
in a region of interest in the genome. The probes are then applied to fixed
cells and hybridise with the (physically intact) genome. The slides can then
be imaged under fluorescence microscopy to locate the region of interest.
We would hope to find that, when averaged across the population, the loci
of lineage specific genes remain in closer proximity to the nuclear envelope
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when compared with controls.
The second approach is to conduct RNA sequencing to find genes that
are di↵erentially regulated by forces acting at the nuclear envelope during
di↵erentiation. By comparing this list with the list of genes that are known
to be enriched at the nuclear lamina, obtained through previously conducted
DamID studies in ES cells, it will be possible to link spatial and transcrip-
tional information. The hope would be to show that there is a positive
correlation between genes that are enriched at the nuclear lamina and those
that are di↵erentially regulated during di↵erentiation when forces on the
nuclear envelope are perturbed.
Both experimental approaches would go a long way towards increasing
our understanding of the role played by forces that act directly on chromatin
in regulating transcriptional changes at the nuclear envelope.
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Appendix A
A.1 Plasmids and oligonucleotides
Plasmids
Name Origin
pCAG LifeAct-TagRFP Ibidi 60107
pCAG LifeAct-TagGFP-ires-Puro Cloned into backbone Ibidi 60107
pCAG TagRPF-LMNB1 Cloned into backbone Ibidi 60107
pPB-EOS-GFP-ires-Puro Gift from Silva lab
pPB-TAP IRI (TetO Hyg Dest) Gift from Silva lab
pDONR221 Gift from Silva lab
pPB-CAG-rtTA Gift from Silva lab
pCyL43 (PBase) Gift from Silva lab
TetO Lmna Hyg Gateway cloned
TetO Lbr Hyg Gateway cloned
TetO mRFP-SR-KASH Hyg Gateway cloned
TetO mRFP-KASH Hyg Gateway cloned
TetO mRFP-KASH L Hyg Gateway cloned
Table A.1: Plasmids used for cloning and transfections. Plasmids kindly
gifted by the Silva lab can be found in Dos Santos et al. (2014).
107
Gateway Primers
Name Sequence
LMNA GATEWAY F GGGGACAAGTTTGTACAAAAAAGC
AGGCTTCGAAGGAGATAGAAC-
CATGGAGACCCCGTCACA
LMNA GATEWAY R GGGGACCACTTTGTACAAGAAAGC
TGGGTCTTACATGATGCT-
GCAGTTCTG
LBR GATEWAY F GGGGACAAGTTTGTACAAAAAAAG
CAGGCGCCACCATGCCAAGTAG-
GAAGTTTGTTG
LBR GATEWAY R GGGGACCACTTTGTACAAGAAAGC
TGGGTATCAGTAAATG-
TAGGGGAATATGCG
mRFP GATEWAY F GGGGACAAGTTTGTACAAAAAAGC
AGGCGCCACCATGGCCTCCTCC-
GAG
KASH GATEWAY R GGGGACCACTTTGTACAAGAAAGC
TGGGTACTATGTGGGGGGTGGC
KASH L R GGGGACCACTTTGTACAAGAAAGC
TGGGTACTAGCAGCTG-
TAGTCTTCTTCG
LMNB1 F IND GGGGACAAGTTTGTACAAAAAAGC
AGGCTCATTTTGGCAAAGAATTA-
GATCC
LMNB1 R IND GGGGACCACTTTGTACAAGAAAGC
TGGGTCTCACATAATG-
GCACAGCTT
LMNB1-tagRFP R IND GGGGACCACTTTGTACAAGAAAGC
TGGGTCTCAATTAAGTTTGTGC-
CCC
Table A.2: Oligonucleotides used for Gateway cloning.
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Sequencing Primers
Name Sequence
SR-KASH F1 GACAGCCCTTCCTGTCCCGA
SR-KASH F2 CGCTCATGCAGTGCCAGGAC
SR-KASH F3 CAGCTGCACTCAGGCCAACA
SR-KASH R1 TATAAGGGGTGCTGGACGCAGG
SR-KASH R2 TGAGCCTTCTGCCTCCGGTT
mRFP R1 CGCGCTCGTACTGTTCCACG
mRFP F1 GGCCAAGAAGCCCGTGCAG
LifeAct-GFP F1 GGCTTCTGGCGTGTGACC
LifeAct-GFP F2 TATCGAATTCCGCCCCTCTC
LifeAct-GFP F3 ACCACCAGGGCAAGGGTCT
LifeAct-GFP F4 TGCACGAGTGGGTTACATCG
LifeAct-GFP R1 CCGCCTTTGCAGGTGTATCT
LifeAct-GFP R2 TCTCATGAGCGGATACATA
LMNA SEQ R AGCCCGCAGCTCCTG
LMNA SEQ R2 CCGTTATCGATCTCCACAA
LMNA SEQ F1 GGCAGGTAGCCAAGCTTG
LMNA SEQ F2 TGGCCCTGGACATGGA
GFP-IRES-Puro SeqR1 AGTTCTTGCAGCTCGGTGAC
GFP-IRES-Puro SeqF1 CCTGAGCAAAGACCCCAAC
tagRFP F1 CATGGGAGAGAGTCACCACA
tagRFP R1 CCTCGGATGTGCACTTGAAG
pCAG F1 TCCCCTTCTCCCTCTCCAG
LMNB1 SEQ1 TCAAGGCTCTCTACGAGACCG
LMNB1 SEQ2 GTACAAGCTGGCTCAAGCCC
LMNB1 SEQ3 GTCCTCCAGTCGCAGTGTG
LMNB1 SEQ4 GCACAGTCTTCAAGACCACCATAC
LBR R1 GGTCCTTCTGCCTGCACTG
LBR R2 TAAAAGGCCTGGAGGCTGTA
LBR F1 GGAAGGACTTGGAGTTTGGA
LBR F2 GAAGCACTGCTGACCTCCAT
Table A.3: Oligonucleotides used for sequencing.
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InFusion Primers
Name Sequence
AmpR R INF GTCCTGATAGCGGTCGGATCTTCA
CCTAGATCCTTTTAA
AmpR F INF CATCGATGATCTAGAAATGTGCGC
GGAACC
GFP-IRES-Puro R GGTTCCGCGCACATTTCTAGATCA
TCGATGCATGG
GFP-IRES-Puro F AAGGGGATCCACCGGTCGCCACCA
TGGTGAGCAA
LMNB1 NTERM F GTACCGGTCCCGCCATGGCGACCG
CGACCCCCGT
LMNB1 NTERM F2 GTACCGGTCCCGCCATGGCGACCG
CG
LMNB1 NTERM R CGACCGGTCCTCCGCACATAATGG
CACAGCTTTT
LMNB1 R INF CATGGTGGCGACCGGTCCTCCGCA
CATAATGGCACAGCTTTT
LMNB1 F INF AATTAGATCCACCGGATGGCGACC
GCG
LMNB1 F INF2 AATTAGATCCACCGGTCCCGCCAT
GGCG
RFP-LMNB1 F INF TCAGATCTCGAGCTCAAGCTTCGA
TGGCGACCGCGAC
RFP-LMNB1 F INF2 TCAGATCTCGAGCTCAAGCTTCGA
TGGCGCCGCGAC
RFP-LMNB1 R INF GAGCTCGAGATCTGAGTCCGGAAT
TAAGTTTGTGCCCCAG
LMNB1-VECT INF ATCTAGAGTCGCGGCCTCACATAA
TGGCACAGCT
LMNB1-VECT INF2 ATCTAGAGTCGCGGCCTCACATAA
TGGCACAGCTTTTATTG
VECT-RFP INF AGAATTAGATCTCGAGCCACCATG
GTGTCTAAG
Table A.4: Oligonucleotides used for In-Fusion cloning.
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A.2 Cell culture media
For 100 ml N2B27
Reagent Conc. /µM Conc. /mgml 1 Volume /ml
Neurobasal Medium - - 49
DMEM F12 Ham - - 49
N2 - - 0.5
B-27 - - 1
L-Glutamine 2.2⇥ 103 - -
2-Mercaptoethanol 1.1⇥ 102 - -
For 100 ml 2i/LIF
N2B27 - - 100
CH99021 (Chiron) 3 - -
PD0325901 (PD03) 1 - -
LIF - 1.0⇥ 10 2 0.22
Table A.5: Cell culture media recipe.
For 10 ml N2
Reagent Conc./mgml 1 Volume /ml
DMEM F-12 Ham - 5.36
Apotransferrin solution 10 -
Insulin 2.5 -
Sodium selenate solution 0.518 -
Putrescine solution 1.6 -
Progesterone solution 1.98⇥ 10 3
BSA - 1
Table A.6: N2 components, made in-house.
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A.3 Antibodies
Primary Antibodies
Name Dilution Catalogue no.
Anti-Lamin B1 1/1000 Abcam ab16048
Anti-Lamin B Receptor 1/200 Abcam ab122919
Anti-Lamin C ? Abcam ab8981
Anti-Emerin ? Abcam ab156871
Anti-Nesprin 1 ? Abcam ab24742
Anti-SUN2 1/200 Abcam ab124916
Anti-SUN1 1/200 Abcam ab103021
Anti-Nuclear Pore Complex Pro-
teins
? Abcam ab50008
Tri-Methyl-Histone H3 (Lys4) 1/1000 Abcam ab8580
Di-Methyl-Histone H3 (Lys9 1/200 Abcam ab1220
Tri-Methyl-Histone H3 (Lys4) 1/400 CST 9751S
Tri-Methyl-Histone H3 (Lys27) 1/1600 CST 9733S
Tri-Methyl-Histone H3 (Lys9) 1/800 CST 13969P
Sox1 1/200 CST 4194S
Lamin A/C 1/200 CST 4777S
Tri-Methyl-Histone H3 (Lys27)
Alexa Fluor 488 Conjugate
1/50 CST 5499S
Anti-Sox1 1/100 R&D Systems AF3369
Anti-Brachyury 1/200 R&D Systems AF2085
Lamin A 1/100 Santa Cruz SC-20680
Secondary Antibodies
Goat anti-Rabbit Alexa Fluor 488 1/400 Thermo Fisher A11008
Goat anti-Mouse Alexa Fluor 488 1/400 Thermo Fisher A21121
Donkey anti-Mouse Alexa Fluor 488 1/400 Thermo Fisher A21202
Donkey anti-Rabbit Alexa Fluor
488
1/400 Thermo Fisher A21206
Donkey anti-Rabbit Alexa Fluor
555
1/400 Thermo Fisher A31572
Donkey anti-Goat Alexa Fluor 555 1/400 Thermo Fisher A21432
Donkey anti-Goat Alexa Fluor 647 1/400 Thermo Fisher A21447
Table A.7: Antibodies used for immunofluorescence.
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A.4 siRNA knockdown
siRNA Knockdown
siRNA Volume /µl Catalogue no.
ON-TARGETplus Mouse LBR 0.5 L-051330-01-0005
siGENOME Mouse Sun1 0.5 M-040715-00-0005
siGENOME Mouse Sun2 0.5 M-041247-01-0005
Scrambled 0.5 D-001810-10-05
RNAiMax Lipofectamine 0.5 See reagent list
2i/LIF or N2B27 100 -
Table A.8: Reagents for siRNA knockdown in 24-well plate format.
A.5 Taqman probes
Taqman Probes
Gene Dye Catalogue no.
Nanog FAM Mm02384862 g1
Rex1 FAM Mm03053975 g1
Oct4 FAM Mm00658129 gH
Klf4 FAM Mm00516104 m1
Tcfcp2l1 FAM Mm00470119 m1
LMNB1 FAM Mm00521949 m1
LMNA/C FAM Mm00497783 m1
Fgf5 FAM Mm03053745 s1
Dnmt3b FAM Mm01240113 m1
Otx2 FAM Mm00446859 m1
Sox1 FAM Mm00486299 s1
Pou3f1 FAM Mm00843534 s1
Brachyury FAM Mm01318252 m1
Sun1 FAM Mm00659179 m1
Sun2 FAM Mm01299500 m1
Lbr FAM Mm00522574 m1
GAPDH VIC 4352339E
Table A.9: TaqMan probes used for qPCR.
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A.6 Kits and reagents
Kits
Name Manufacturer Catalogue no.
QIAquick Gel Extraction Kit Qiagen 28704
QIAquick PCR Purification Kit Qiagen 28104
QIAprep Spin Miniprep Kit Qiagen 27104
RNeasy Mini Kit Qiagen 74104
Plasmid Maxi Kit Qiagen 12162
Plasmid Mini Kit Qiagen 12123
RNase-Free DNase Set Qiagen 79254
PureLink Plasmid Miniprep Kit Invitrogen K210010
Alkaline Phosphatase Kit Millipore SCR004
Reagents
MicroAmp 96-Well Reaction Plate Applied Biosystems 4346907
TaqMan Master Mix Applied Biosystems 4352042
8-Strip PCR Caps STARLAB I1400-0900
Clear Polyolefin StarSeal STARLAB E2796-9793
Gateway BP Clonase II Invitrogen 11789-020
Gateway LR Clonase II Invitrogen 11791-020
SuperScript III First-Strand SS Invitrogen 18080-051
Zeocin Invitrogen 45-0430
Hygromycin B Invitrogen 10687-010
Lipofectamine 2000 Reagent Invitrogen 11668-030
Lipofectamine RNAiMAX Reagent Invitrogen 13778-100
mLIF Homemade Biochem
N2 Homemade SCI
Table A.10: Kits and reagents.
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Reagents
Name Manufacturer Catalogue no.
Neurobasal Medium Gibco 21103-049
DMEM F-12 Ham Gibco 21331-020
Geneticin G418 Gibco 10131-035
L-Glutamine Gibco 25030-081
B-27 Supplement Gibco 17504-044
2-Mercaptoethanol Gibco 21985023
Q5 Hot Start HF DNA Polymerase New England Biolabs M0493S
µ-Dish 35mm, high Ibidi 81156
E.cloni 10G DUOs Lucigen 60107
Corning Fibronectin, Human Fisher Scientific 354008
Jasplakinolide Cambridge Bioscience CAY11705-100
SiR-DNA (SiR-Hoechst) Spirochrome AG SC007
CH99021 Sigma-Aldrich SML1046
PD0325901 Sigma-Aldrich PZ0162
Laminin Sigma-Aldrich L2020
GMEM Sigma-Aldrich G5154
Dulbecco’s Phosphate Bu↵ered Saline Sigma-Aldrich D8537
Blebbistatin Sigma-Aldrich B0560
Nocodazole Sigma-Aldrich M1404
Y-27632 Sigma-Aldrich Y0503
Hoechst 33342 Sigma-Aldrich B2261
Table A.11: Reagents continued.
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